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"[One] topic we touched on was mutation ... We totally missed the possible role of … 
[DNA] repair although … I later came to realise that DNA is so precious that probably 
many distinct repair mechanisms would exist. Nowadays, one could hardly discuss 
mutation without considering repair.” 
Francis Crick in "The double helix: a personal view" (Crick, 1974). 
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1 Introduction 
 
1.1 DNA repair 
DNA, the carrier of genetic information, is constantly threatened by a variety of damaging 
agents. Sources of DNA damage can be either exogenous (like chemicals or radiation) or 
endogenous (reactive metabolites like oxygen radicals or replication errors). They affect 
either the nucleobases or the backbone of the DNA helix (Lodish et al., 2000; 
Hoeijmakers, 2001). Examples for common DNA lesions are listed in table 1.1. 
 
Table 1.1:  DNA damage types (according to Lodish et al., 2000; Hoeijmakers, 
2001). 
DNA damage types Examples Caused by 
Base modifications Oxidation: 8-oxoguanine  
Alkylation: 7-methylguanine 
Deamination of cytosine to uracil 
Oxygen radicals 
Alkylating reagents 
Spontaneous deamination 
Mismatches G/T or A/C pairs Replication errors 
Breaks in the backbone Single strand breaks (SSBs) 
Double strand breaks (DSBs) 
Ionizing radiation or chemicals  
Bulky photoadducts Cyclobutane-pyrimidine dimers  
(CPDs), 6-4-Photoproducts 
UV radiation 
Cross-links Intrastrand cross-links 
Interstrand cross-links 
Cross-linking agents 
(bifunctional alkyklating agents) 
 
 
If left unrepaired, these DNA lesions can lead to mutations – which may in higher 
organisms result in cancer – or cell death.  
DNA damaging agents are often used as chemotherapeutics in cancer therapy in order to 
inhibit DNA replication and therefore stop cell division. In particular, DNA cross-linking 
agents, e.g cis-diammine dichloroplatinum(II) (cisplatin) or mitomycin C, are applied 
(Jamieson and Lippard, 1999; Siede et al., 2005). 
Cells have evolved multiple repair mechanisms, which use different enzymes and deal with 
different kinds of lesions (see table 1.2) (reviewed in Lindahl and Wood, 1999; 
Hoeijmakers, 2001; Alberts et al., 2002; Siede et al., 2005; Friedberg et al., 2006). In 
humans, several inherited disorders were found to be associated with defects in DNA 
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damage repair genes (see chapters 1.1.1.2. and 1.1.2.5.). Many of these syndromes are 
characterized by premature ageing and cancer predispositions (Hoeijmakers, 2001). 
 
Table 1.2:  DNA repair systems (Friedberg et al., 2006) 
Repair mechanism Repair systems Applied to 
Direct damage 
reversal 
Photoreactivation  
Oxidative demethylation 
Ligation of SSBs 
Photoproducts (CPDs) 
Alkylated bases 
SSBs 
Damage removal 
(Excision repair) 
Nucleotide excision repair (NER) 
  - Global genome repair (GGR) 
  - Transcription coupled repair (TCR) 
Base excision repair (BER) 
Mismatch repair (MMR) 
Bulky, helix-distorting lesions  
like photoproducts, cisplatin- 
adducts, or cross-links 
Modified bases 
Single-base mispairs 
Double strand break 
(DSB) repair 
Homologous recombination (HR) 
Non-homologous end-joining (NHEJ) 
Double strand breaks 
Damage tolerance Trans-lesion synthesis (TLS)  
 
 
In the following chapters, the repair systems of nucleotide excision repair (NER) and 
transcription-coupled repair (TCR) will be described in more details. 
 
1.1.1 Nucleotide excision repair 
Nucleotide excision repair (NER) is a functionally conserved DNA repair system which 
can be found in all kingdoms of life (Sancar, 1996; Ogrunc et al., 1998; Batty and Wood, 
2000). NER deals with a broad range of chemically and structurally unrelated helix-
distorting DNA lesions like UV-induced photoproducts, bulky chemical adducts as well as 
inter- and intrastrand cross-links (Sancar and Rupp, 1983; Batty and Wood, 2000; Van 
Houten et al., 2005). The basic NER mechanisms have been strongly conserved throughout 
evolution, although the enzymes involved in the process differ between prokaryotes and 
eukaryotes (Batty and Wood, 2000). Interestingly, some mesophilic Archaea use the 
bacterial system, while in most Archaea, proteins homologous to eukaryotic nucleotide 
excision repair factors are found (Kelman and White, 2005). 
 
 Introduction  3 
1.1.1.1 NER in bacteria 
In bacteria (and in some archaea as well), nucleotide excision repair is mediated by the 
UvrABC system (reviewed in Batty and Wood, 2000; Van Houten et al., 2005; Truglio et 
al. 2006).  
 
Upon ATP-binding, UvrA dimerizes (Mazur and Grossman, 1991) and forms a complex 
with UvrB which contains either the UvrA2-UvrB1 heterotrimer (Orren and Sancar, 1989) 
or the UvrA2-UvrB2 heterotetramer (Verhoeven et al., 2002). This so-called UvrAB 
damage-recognition complex binds to DNA and scans the molecule for sites of helix-
distorting DNA lesions.  
The role of the second UvrB subunit is still being discussed. The UvrA-dimer seems to 
interact directly with only one UvrB molecule, while the second UvrB binds to the first 
one. The UvrB-dimer is proposed to function in damage recognition in both DNA strands. 
The second UvrB dissociates upon UvrC-binding (Hildebrand and Grossman, 1999; 
Verhoeven et al., 2002). 
After damage verification, UvrB is loaded onto the damaged DNA, and UvrA dissociates 
from the lesion site (Orren and Sancar, 1989; Sancar and Hearst, 1993). DNA becomes 
wrapped around UvrB (Verhoeven et al., 2001), and UvrB inserts a hairpin motif ("β-
hairpin") into the DNA duplex (Truglio et al., 2006b). This step is energy-dependent and 
requires ATP hydrolysis both by UvrA and UvrB (Van Houten et al., 1988; Moolenaar et 
al., 2000). UvrB possesses cryptic helicase activity (Orren and Sancar, 1989; Theis et al., 
2000; Verhoeven et al., 2002) which is proposed to function in destabilization of the 
double-helix, so that UvrB can insert the β-hairpin between the two strands (Skorvaga et 
al., 2004; Truglio et al., 2006a). A kinetic analysis has shown that the formation of the 
UvrB-DNA pre-incision complex (PIC) is the rate-limiting step of the NER process (Orren 
and Sancar, 1990). 
UvrC is then recruited to the lesion. The UvrB C-terminus interacts with a homologous 
region located in the N-terminal half of UvrC (Moolenaar et al., 1998; Sohi et al., 2000) 
UvrC mediates two incisions in the damaged strand (Lin and Sancar, 1992; Verhoeven et 
al., 2000): The first incision takes place 3 or 4 nucleotides 3’ to the lesion. This step 
requires ATP-binding by UvrB (Orren and Sancar, 1990; Moolenaar et al., 2000; Goosen 
and Moolenaar, 2001; Truglio et al., 2005). The second incision by UvrC is independent of 
UvrB. It occurs at the eighth phosphodiesterbond 5’ to the damage site (Moolenaar et al., 
1995). The first incision is performed by the N-terminal part of UvrC, while the C-terminal 
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half mediates the 5’-incision. UvrD (helicase II) mediates removal of UvrC and the excised 
12- or 13-mer oligonucleotide. DNA polymerase I displaces UvrB and filles the gap. The 
DNA is finally sealed by DNA ligase (Caron et al., 1985; Husain et al., 1985). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Bacterial nucleotide excision repair is mediated by the UvrABC system 
(adopted from Goosen and Moolenaar, 2001). The mechanism of this 
repair pathway is described in the text (DNA lesion, red star; UvrA, 
orange; UvrB, green; UvrC, blue). 
 
A second endonulease in nucleotide excision repair, Cho (UvrC homologue), was recently 
identified. Cho is a homologue to the N-terminal part of UvrC. Moolenaar and colleagues 
pointed out that, in the presence of UvrA and UvrB, Cho can perform the 3’ incision to 
damaged DNA. The incision takes place 4 nucleotides further downstream than the UvrC-
mediated cleavage. The incised DNA is further processed by UvrC (Moolenaar et al., 
2002).  
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1.1.1.2 Comparison of NER in eukaryotes to the bacterial system 
Nucleotide excision repair in eukaryotic cells shows many remarkable similarities to the 
bacterial system. The general mechanism is highly conserved, but different proteins are 
used in the repair process. While bacteria require only three proteins – UvrA, UvrB and 
UvrC – for damage recognition and the incision reactions, human NER uses up to 19 
polypeptides for these steps (table 1.3) (Sancar, 1996; Batty and Wood, 2000; Coin et al., 
2006). 
 
Table 1.3:  Proteins involved in bacterial and eukaryotic nucleotide excision repair 
(adopted from Batty and Wood, 2000). 
 bacteria human (yeast) 
Damage recognition UvrA2B1/2  XPC–hHR23B (Rad4–Rad23) 
Opening, pre-inscision complex UvrB XPA (Rad14), RPA, TFIIH 
3'-incision UvrC XPG (Rad2) 
5'-incision UvrC    ERCC1–XPF (Rad10–Rad1) 
Excison, repair synthesis UvrD, PolI, ligase PCNA, ligase, RFC, RPA, Pol δ/ε 
 
 
Humans deficient in nucleotide excision repair suffer from xeroderma pigmentosum (XP), 
a rare, recessively inherited disease which is mainly characterized by extreme UV 
sensitivity, parchment skin ("xeroderma") and freckles ("pigmentosum"). XP is associated 
with an increased risk to develop malignancies, especially skin cancers (Cleaver and 
Kraemer, 1995; de Boer and Hoeijmakers, 2000; Andressoo and Hoeijmakers, 2005).  
 
1.1.2 Transcription-coupled DNA repair 
Damage repair in active genes occurs much faster than in the overall genome. This 
phenomenon is not due to the better accessibility of transcribed DNA regions. It could be 
shown that the higher repair rate is only true for the transcribed strand, while the non-
transcribed strand is repaired at the same rate than the overall genome. These observations 
lead to the discovery of a mechanism called transcription-coupled repair (TCR) (Mellon et 
al., 1986; Mellon et al., 1987; Mellon and Hanawalt, 1989). Transcription-coupled repair is 
present in eukaryotes as well as in prokaryotes. 
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1.1.2.1 Transcriptional arrest and rescue 
RNA polymerase (RNAP) pauses frequently during transcriptional elongation (Fish and 
Kane, 2002). This transcriptional pausing is a temporary interruption of transcription. 
Paused polymerase slowly changes its conformation and isomerizes to an arrested state 
which is accompanied by reverse movement ("backtracking") by several nucleotides 
(Komissarova and Kashlev, 1997). In this position, the active site is not aligned with the 
RNA 3’- hydroxyl end, and RNA polymerase cannot resume transcription by itself. In 
theory, a single RNA polymerase molecule which is stalled irreversibly in an essential 
gene could cause cell death (Svejstrup, 2002a).  
Transcriptional arrest may occur in case of nucleotide starvation or when RNA polymerase 
encounters a roadblock like a DNA-binding protein (Komissarova and Kashlev, 1997; Fish 
and Kane, 2002). In addition, intrinsic signals in DNA and RNA have been identified to 
cause pausing or arrest of RNA polymerase (Artsimovitch and Landick, 2000). 
Transcription factors (GreA/GreB in bacteria, TFIIS in eukaryotes) are required to 
reactivate arrested RNA polymerase by inducing internal cleavage of the RNA (Reines et 
al., 1992; Tornaletti et al., 1999; Kettenberger et al., 2003; Nickels and Hochschild, 2004). 
Thereby, a new 3’-OH-end is created, and transcription proceeds in the correct DNA-RNA 
register (Borukhov et al., 1993). 
However, one of the most common causes for transcriptional arrest is a non-coding lesion 
in the transcribed DNA strand (Tornaletti and Hanawalt, 1999), over which transcription 
cannot continue. Instead, dissociation of the transcription elongation complex and 
recruitment of damage repair proteins take place. This process is known as transcription-
coupled repair (TCR) (reviewed in Svejstrup, 2002a; Mellon, 2005; Saxowsky and 
Doetsch, 2006). 
TCR is mainly considered as a sub-pathway of nucleotide excision repair (NER), but Le 
Page and colleagues could demonstrate recently that TCR also plays a role in the base 
excision repair (BER) system (Le Page et al., 2000). 
 
1.1.2.2 The Mfd protein is the bacterial transcription-repair coupling factor 
In Escherichia coli, the Mfd protein was identify to be responsible for connecting the 
processes of transcription and DNA repair. Mfd is therefore also termed transcription–
repair coupling factor (TRCF) (Selby et al., 1991).  
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Mfd was already discovered in the 1960s by E. Witkin in a genetic screen. Mutation 
frequency decline (Mfd) stands for a rapid decrease in the frequency of occurring nonsense 
suppressor mutations when protein synthesis is transiently inhibited immediately after UV-
irradiation (Witkin, 1966). In cells lacking the mfd gene product this phenomenon is 
strongly reduced. Additionally, mfd - cells are characterized by a high spontaneous 
mutation rate, increased sensitivity to UV, and a decreased damage repair rate (Selby and 
Sancar, 1993). Furthermore, it could be shown that mfd - cells are incapable of strand-
specific repair. This defect could be complemented by adding purified Mfd protein (Selby 
et al., 1991). 
 
Recently, Park and colleagues could demonstrate that Mfd is able to rescue stalled RNA 
polymerase to resume transcription elongation. Mfd binds to template DNA upstream of 
the transcription machinery. In contrast to GreA/GreB, Mfd acts by translocating the 
backtracked transcription elongation complex forward. Thereby, the catalytic center is 
realigned with the original 3′-OH end of the transcript, and RNA synthesis is allowed to 
resume (Park et al., 2002) (figure 1.2, left panel).  
However, if RNA polymerase is blocked by non-coding lesions, productive transcription 
cannot proceed. In this case, Mfd induces dissociation of the RNA polymerase from 
template DNA in an ATP-dependent manner (Selby and Sancar, 1995b; Selby and Sancar, 
1995a; Park et al., 2002) (figure 1.2, right panel). Mfd is suggested to induce the 
dissociation of RNA polymerase by pushing it hard over the damage (Park et al., 2002). 
Mfd, remaining bound at the lesion, then recruits the nucleotide excision repair machinery. 
Mfd interacts with UvrA and recruits the UvrA-UvrB complex to the damage site (Selby 
and Sancar, 1993). Therefore, Mfd can be considered both as a transcription elongation 
factor (Park et al., 2002; Borukhov et al., 2005) and as a terminator of transcription 
(Roberts and Park, 2004).  
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Figure 1.2:  Mechanism of bacterial TCR (adopted from Svejstrup, 2002b; Roberts 
and Park, 2004; Mellon, 2005). Left panel: RNA polymerase 
(transparent box) is stalled in the backtracked position, the active site 
and the 3’-end of the RNA (light blue) are not aligned. Mfd (yellow 
sphere) recognizes stalled RNA polymerase and binds upstream of the 
transcription elongation complex. Subsequently, Mfd induces forward 
translocation leading to resumption of transcription (left). Right panel: If 
RNAP is blocked by DNA damage (red star), transcription elongation 
cannot resume. Mfd promotes release of RNA polymerase and RNA from 
the transcribed DNA followed by recruitment of the UvrABC nucleotide 
excision repair system (UvrA, orange; UvrB, green). 
 
The mechanism of UvrAB recruitment and the subsequent formation of the UvrB-DNA 
pre-incision complex at stalled transcription sites, however, are not fully understood. 
 
1.1.2.3 Domain architecture and biochemical properties of Mfd 
Mfd is a highly conserved monomeric protein. With 1148 residues (130 kDa), it is among 
the largest 1% of all Escherichia coli proteins (Roberts and Park, 2004). Selby and Sancar 
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could show that Mfd consists of distinct functional regions (figure 1.3) (Selby and Sancar, 
1995a; Roberts and Park, 2004). 
 
The N-terminal third of Mfd is involved in UvrA binding. It will be described in more 
detail in chapter 1.1.2.4. 
The RNA polymerase interacting domain of Mfd (RID, residues 379-571) binds to the 
N-terminus (the first 142 residues) of the RNA polymerase β subunit, near the upstream 
junction of the transcription bubble (Selby and Sancar, 1995a; Park et al., 2002; Smith and 
Savery, 2005). In the presence of the σ70 factor, RNAP binding by Mfd is blocked (Park et 
al., 2002). 
 
 
 
 
 
 
 
Figure 1.3:  Functional domains of the E.coli Mfd protein (adopted from Selby and 
Sancar, 1995a/b; Roberts and Park, 2004). Residues 1-378, orange: 
UvrA-binding domain, includes UvrB homology region (residues 82-219, 
light orange); residues 379-571, green: RNA polymerase interacting 
domain (RID); residues 598-968, yellow: RecG homology domain, 
includes dsDNA translocase region with superfamily II helicase motifs 
(red) and translocation in RecG (TRG) motif (residues 926-965, violet); 
residues 1005-1113, grey: TRCF domain. 
 
A module related to superfamily II helicases is located in the C-terminal half of Mfd 
(Gorbalenya et al., 1989; Selby and Sancar, 1993; Mahdi et al., 2003).  
This section of the protein bears the DNA binding region and contains the DNA-stimulated 
ATPase activity of Mfd. Binding to preferentially double stranded polynucleotides requires 
ATP binding while ATP hydrolysis promotes dissociation (Selby and Sancar, 1995a). 
Despite its homology to the RecG helicase, Mfd possesses no strand-separating activity. It 
is rather believed to function as dsDNA translocase (Selby and Sancar, 1995b).  
In addition, Mfd and RecG have a helical hairpin motif in common, termed TRG 
(translocation in RecG) motif which is situated downstream of the translocase domain 
(Chambers et al., 2003; Mahdi et al., 2003). Mutational analysis confirmed that the TRG 
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motif in Mfd is required for its RNA polymerase displacement activity (Chambers et al., 
2003).  
The C-terminal TRCF domain (residues 1005-1113; pfam03461) contains a leucine zipper 
motif (L1039, L1046, L1053, L1060). It is essential for RNAP release from damaged DNA 
(Selby and Sancar, 1993). 
 
1.1.2.4 UvrA binding 
Mfd acts as a platform for recruiting the nucleotide excision repair machinery to DNA 
lesions by binding to UvrA (Selby and Sancar, 1993). This process involves the 
N-terminus of Mfd. A truncated mutant of Mfd lacking the first 378 residues was shown to 
be defective in UvrA binding (Selby and Sancar, 1995a). 
The UvrA-binding region bears a section with close homology to a region in the nucleotide 
excision repair protein UvrB: Residues 82–219 of Mfd are 22 % identical (62 % 
homologous) to residues 114-251 of UvrB from the same organism (Selby and Sancar, 
1993) (figure 1.4). In both proteins, this section has been shown to play a role in UvrA 
binding in vitro (Hsu et al., 1995; Selby and Sancar, 1995a; Truglio et al., 2004).  
There is some evidence that Mfd and UvrB utilize a similar mode of binding to UvrA. In 
addition to the high sequence homology in the domain 2, Mfd is able to displace UvrB 
from UvrA in vitro (Selby and Sancar, 1993).  
 
 
  EcoMfd      82  SPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCPHSFLHGHALVMKKGQRLSRDAL  141 
  EcoUvrB    114  SVNEHIEQMRLSATKAMLERRDVVVVASVSAIYGLGDPDLYLK-MMLHLTVGMIIDQRAI  172 
  BcaUvrB    115  KINDEIDKLRHSATSALFERRDVIIVASVSCIYGLGSPEEYRE-LVVSLRVGMEIERNAL  173 
 
 
  EcoMfd     142  RTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMG-SELPYRLDFFDDEIDSLRVFDVDSQ  200 
  EcoUvrB    173  LRRLAELQYARNDQAFQRGTFRVRGEVIDIFPAESDDIALRVELFDEEVERLSLFDPLTG  232 
  BcaUvrB    174  LRRLVDIQYDRNDIDFR-GTFRVRGDVVEIFPASRDEHCIRVEFFGDEIERIREVDALTG  232 
 
 
  EcoMfd     201  RTLEEVEAINLLPAHEFPT  219 
  EcoUvrB    233  QIVSTIPRFTIYPKTHYVT  251 
  BcaUvrB    233  KVLGEREHVAIFPASHFVT  251 
 
Figure 1.4:  Sequence alignment of residues 82-219 of Escherichia coli Mfd (EcoMfd) 
with the corresponding regions of the UvrB proteins from E.coli 
(EcoUvrB, residues 114-251) and Bacillus caldotenax (BcaUvrB, 
residues 116-251). Conserved residues are shaded, dark indicating 
stronger conservation. 
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So far, several molecular structures of UvrB are known. While domain 2 was not defined 
in the first crystal structures solved (Machius et al., 1999; Nakagawa et al., 1999; Theis et 
al., 1999), it was visible in the UvrB variant Y96A from Bacillus caldotenax (Truglio et 
al., 2004).  
Residues 157-245 form a compact globular domain (denoted domain 2). The structure of 
this domain revealed a new fold according to structural analysis by Distance matrix 
alignment (Dali) (Holm and Sander, 1995). Furthermore, some highly conserved residues 
located on its surface could be identified to be essential for UvrA binding (Truglio et al., 
2004). Until 2005, no structure of Mfd was known.  
 
1.1.2.5 Eukaryotic TCR 
The phenomenon of transcription-coupled repair is conserved. However, TCR in 
eukaryotic cells is much more complex than in bacteria and less well studied. Thus, many 
details are not fully understood (Svejstrup, 2002a; Laine and Egly, 2006; Saxowsky and 
Doetsch, 2006). 
In eukaryotic TCR, RNA polymerase II (RNAPII) functions as the damage recognition 
factor. Stalled RNAPII is recognized by the proteins XPG and CSB which then recruit, 
among others, TFIIH and CSA. Excision of the damaged oligonucleotide and repair 
synthesis in TCR share the protein repertoire with global genome NER (see 1.1.1.2).  
 
Table 1.4:  Eukaryotic proteins involved in transcription coupled repair (adopted 
from Svejstrup, 2002a; Laine and Egly, 2006; Saxowsky and Doetsch, 
2006). Repair factors marked with a star (*) are involved both in GGR 
and in TCR. 
human (yeast) factors activities interaction partners 
CSA (Rad28) E3 ubiquitin ligase CSB, XAB2, TFIIH 
CSB (Rad26) Swi2/Snf2, DNA binding CSA, XA2B, TFIIH, RNAPII, XPA; XPG  
XAB2 (Syf1)  CSA, CSB, RNAPII, XPA 
TFIIH (TFIIH)  * 
(Egly, 2001) 
10 subunits including 2 
helicases and a cyclin-
dependent protein kinase 
CSA, CSB, RNAPII, XPG 
XPG (Rad2) * 
endonuclease  
(3’-incision) 
CSB, RNAPII 
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Recent findings suggest that the damage is repaired without prior removing RNAPII. 
TFIIH is thought to induce conformational changes by use of the helicase subunits XPB 
(Rad25) and XPD (Rad3) (Sarker et al., 2005). A very current model proposes removal of 
RNA polymerase II together with the lesion (Brueckner et al., 2006). 
 
Mutations in TCR genes (mainly in the genes encoding for CSA or CSB) lead to a severe 
hereditary disorder named Cockayne’s syndrome (CS). CS is characterized by 
photosensitivity, growth retardation, skeletal and retinal abnormalities and progressive 
neural degradation. In contrast to xeroderma pigmentosum, CS is not associated with an 
increased risk of skin cancer or other type of malignancy (Nance and Berry, 1992; de Boer 
and Hoeijmakers, 2000; Andressoo and Hoeijmakers, 2005). 
 
1.2 Structure determination by X-ray crystallography 
1.2.1 Structural biology 
Proteins consist of one or more chains of amino acids that fold into three-dimensional 
structures. The structure of a protein is intrinsically related to its function. Therefore, 
structure determination of biological macromolecules is a powerful tool to gain 
information on their biological function and on their mechanism. In addition, structural 
studies play an important role in protein design and drug development. 
 
Several methods have been developed to determine three-dimensional structures of 
molecular machines with atomic resolution: 
Electron microscopy (EM) is a powerful tool for the determination of large structures, e.g. 
complexes, organelles or cells. At present, electron cryo-microscopy (cryo-EM) and, in 
particular, the reconstruction of single-particles can in practice reach a resolution of 4-5 Å. 
However, its application to small molecules is limited. So far, EM can be used only for 
particles with a size of at least several hundred kDa (R. Beckmann, DNA repair workshop, 
July 20, 2006).  
In contrast, nuclear magnetic resonance spectroscopy (NMR) can only be applied to small 
proteins (usually 20-30 kDa). Structures are determined in solution. Therefore, NMR 
allows time-resolved studies (e.g. folding analysis or kinetics).  
X-ray crystallography is a very high resolution method. It has no limitation with respect of 
molecular weight. However, in order to determine a structure by X-ray diffraction, the 
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molecule of interest needs to be crystallized which is the major obstacle in this technique 
(see below). Furthermore, a crystal structure can be considered as a "snapshot". Usually, a 
crystal structure provides only very little insight into dynamics.  
The first protein crystal structure solved was that of sperm whale myoglobin in the 1950s 
(Kendrew et al., 1958). In 1962, Max Ferdinand Perutz and Sir John Cowdery Kendrew 
were awarded the Nobel Prize in Chemistry “for their studies of the structures of globular 
proteins” (http://nobelprize.org/chemistry/laureates/1962/index.html).  
So far, over 37,000 biological macromolecular structures have been deposited in the RSCB 
Protein Data Bank (PDB). Most of them (> 90 %) were determined using X-ray 
crystallography (table 1.5). 
 
Table 1.5:  Biological macromolecular structures in the RSCB Protein Data Bank 
(PDB) (source: http://www.rcsb.org/pdb/holdings.do; June 20, 2006). 
 
Proteins 
Nucleic 
acids (NA) 
Protein/ NA 
complexes Other Total 
X-ray 29258 902  1353  28 31541  
NMR 4690  705  121  6  5522  
EM 88  9  29  0  126  
Other 73  4  3  0  80  
Total 34109  1620  1506  34  37269  
 
1.2.2 Structure determination by X-ray crystallography 
The theoretical background of structure determination by X-ray diffraction will be briefly 
described in the following part. More detailed information can be found in textbooks (e.g. 
Drenth, 1999; McPherson, 2001; Blow, 2002; Massa, 2002). 
 
1.2.2.1 Theory of X-ray diffraction 
X-rays are electromagnetic waves with a wavelength in the range of atomic distances 
(10-10 m = 1 Å). For typical X-ray diffraction experiments, wavelengths between 1.6 and 
0.8 Å are used. When an electron is hit by an X-ray photon, it is set into vibration at the X-
ray frequency. The vibrating electron emits spherical waves of the same wavelength as the 
original wave (elastic scattering).  
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The scattering power of a single molecule in solution is insufficient to generate a 
detectable signal. Therefore, the molecule of interest needs to be crystallized (see 2.7.1). 
Crystals are highly ordered structures, where a unit cell containing the molecule of interest 
is periodically repeated in a three dimensional lattice. Waves scattered from different 
atoms in a crystal may interfere, and, depending on the phase difference, amplify or damp 
each other. If the phase shift is proportional to 2π (“in-phase”), the signal is enhanced, and 
diffraction occurs. The conditions for this constructive interference are given by the Laue 
equations and Bragg's law. 
According to Sir W. H. Bragg and Sir W. L. Bragg, X-ray diffraction by a crystal can be 
considered as reflections at imaginary lattice planes. Lattice planes are characterized by the 
Miller indices (hkl) which represent their orientation in the crystal lattice and the spacing 
between parallel planes.  
A signal can only be detected if the distance d and the angle θ between the planes and the 
incident beam follow the rule (“Bragg’s law”) 
θdλn sin2 ⋅⋅=⋅  
where n is an integer, and λ is the wavelength of the X-rays.  
Each diffraction spot (h,k,l) corresponds to a reflection at a set of parallel lattice 
planes (hkl).  
 
1.2.2.2 Structure factors and electron density  
The structure factor F is a mathematical description of how the crystal scatters incident 
radiation. F(h,k,l) is the sum of the scattering contributions of all N atoms in the unit cell to 
a reflection (h,k,l).  
[ ] [ ]22
1
/sinexp2exp λθ⋅−⋅++⋅⋅= ∑
=
i
N
j
jjjj B)lzkyi(hxπfF(h,k,l)  
The atomic scattering factor (or form factor) fj describes the scattering power of an atom j 
and is dependent on the atom type. The last term of structure factor, the Debye-Waller 
factor (B-factor), represents the effect of thermal disorder. 
The electron density ρ of molecules in a crystal is a three-dimensional repetitive structure. 
It represents the scattering power of all atoms in the unit cell. Electron density and 
structure factor are related by Fourier transform (FT): The variation of electron density in a 
crystal can be used to determine the relative amplitudes and phases of the Fourier 
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coefficients, the structure factors, by direct FT. Reversely, structure factors can be used to 
calculate electron density by inverse FT.  
 
Fourier integral (direct FT): 
[ ] dx dy dzlz)ky(hxπρ(x,y,z)VF(h,k,l)
zyx
++⋅⋅⋅= ∫∫∫
===
2exp
1
0
1
0
1
0
 
 
Fourier series (inverse FT): 
 [ ]∑ ++⋅−⋅=
hkl
lz)kyi(hxπF(h,k,l)
V
ρ(x,y,z) 2exp1  
 
The structure factor F(h,k,l) is a complex number which is formed by the amplitude 
|F(h,k,l)| and the phase φ(h,k,l) of a scattered wave.  
[ ]),,(exp),,( lkhilkhFF(h,k,l) φ⋅⋅=  
Both amplitude and phase are required for the calculation of an electron density from 
structure factors. While the amplitude can be derived from the reflection intensity (I ~ |F²|), 
the phase cannot be directly observed from a diffraction pattern. This is referred to as the 
“phase problem” of crystallography.  
 
Phase angles can be obtained by several approaches:  
If a model for a related molecule is available, it can be used for phase determination by 
molecular replacement (MR). For de novo phasing, heavy atom methods like isomorphous 
replacement (SIR/MIR) or anomalous dispersion (SAD/MAD) are generally used. Direct 
methods can be applied only to very small molecules or substructures.  
In this PhD thesis, a multiple-wavelength anomalous diffraction (MAD) experiment was 
carried out using selenium. 
 
1.2.2.3 Phasing by use of anomalous dispersion 
If the incident beam possesses an energy close to the eigenfrequency of an atom, some 
photons are absorbed and re-emitted either at lower energy (fluorescence) or at the same 
energy with a phase-delay (anomalous dispersion). In case of anomalous dispersion, the 
atomic scattering factor fano gains an anomalous contribution which is composed of a real 
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if" 
f'=f0-∆f 
∆f
f0 
fano
part ∆f and an imaginary part if". The phase of the imaginary part if'' is always shifted by 
+90° (figure 1.5). 
'0 if'f'if''∆fff ano +=+−=  
 
 
 
 
 
 
 
Figure 1.5:  The anomalous atomic scattering factor fano. The anomalous contribution 
to the atomic scattering factor is composed of a real part ∆f and an 
imaginary component if''. 
 
Light atoms normally occuring in biological molecules (e.g. carbon, nitrogen or oxygen) 
do not have transitions in the range of energies that are used in X-ray diffraction 
experiments. Therefore, heavy metal atoms (e.g. selenium, mercury, platinum etc.) are 
introduced into proteins. These elements show detectable anomalous scattering at X-ray 
wavelengths. In this case, scattering can be described as a sum FPH of the normal scattering 
from light protein atoms FP and scattering from heavy atoms FH with a normal (FHN) and 
an anomalous part (FHA): 
HAHNPHPPH FFFFFF ++=+=  
The anomalous signal is dependent on the energy of the X-rays and hence depends on the 
applied wavelength. Thus, differences in the reflection intensities recorded at different 
wavelengths close to the absorption edge can be observed. 
A consequence of anomalous scattering is the violation of the Friedel's law: In normal 
scattering, the structure factors describing the reflections (h,k,l) and (–h,–k,–l) have the 
same amplitudes and opposite phases. FP(h,k,l) and FP(–h,–k,–l) are called Friedel mates. 
In contrast, amplitudes of anomalous structure factors FPH(h,k,l) and FPH(–h,–k,–l) (now 
named a Bijvoet pair) do not have same magnitudes. 
f''
f'l)kh(Fl)k(hF(d PHPHano 2
,,,, ⋅−−−−=  
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Using the Bijvoet differences dano, the heavy atom substructure can be localized by 
Patterson methods and/or direct methods.  
 
The Patterson function P(u,v,w) does not require phase information. It represents a Fourier 
transform of squared reflection amplitudes |F(h,k,l)| (≈ intensities). By use of this function, 
a map showing interatomic distance vectors (u,v,w) is obtained. 
( ) [ ]∑ ++⋅−=
hkl
hkl lwkvhuiFwvuP )(2exp,,
2 π  
The Patterson function calculated with differences in anomalous amplitudes results in a 
map showing only vectors between the anomalous scatterers. Using this map, heavy atoms 
can be located in the unit cell. With their coordinates, the contribution of the heavy atoms 
to the structure factors can be determined. Finally, protein phase angles can be derived, and 
an electron density can be calculated: 
HHPPPH FFF φφ ⋅+⋅= ||||  
The anomalous contribution to diffraction is generally very small. An MAD experiment 
requires synchrotron radiation which is brighter and less noisy than radiation generated by 
home sources. In addition, synchrotron sources produce continuous X-ray spectra, and the 
monochromatic beam is tuneable to the required wavelengths.  
In a typical MAD experiment, datasets at three wavelengths are recorded:  
A "peak" dataset at the wavelength with maximum f'', a dataset at the "inflection point" 
with minimal f', and a "high energy remote" dataset, where f' is close to normal. 
The resonance wavelength of a certain atom is defined by the atom type. But as it can 
differ slightly dependent on the chemical environment, the exact wavelengths are 
determined experimentally (figure 1.6). The f'' value can be directly obtained by a 
fluorescence scan on the crystal, while f' can be derived from f'' by the Kramer-Kronig 
equation: 
∫
∞
−
=
0
22
2
ω'ω
'ω'f'(ω')δω
π
f'  
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Figure 1.6:  Fluorescence scan on selenomethionine containing crystal of Mfd-N2 
around the selenium K-edge (12.6578 kEV). Values of f' and f'' are 
plotted against the X-ray energy (kEV). Wavelengths used in an MAD 
experiment are indicated. 
 
Today, many structures are solved using anomalous data collected at only one wavelength 
(single-wavelength anomalous diffraction, SAD). 
In recent years, experimental phase information could even be obtained directly from 
native protein crystals using anomalous scattering from sulfur atoms. In this approach, data 
is typically collected at one wavelength far from the absorption edge (5.02 Å). Because of 
the very weak anomalous contributions, highly accurate and redundant data are required.  
 
1.3 Objectives 
DNA damage repair plays an essential role in the maintenance of genomic integrity. 
Nucleotide excision repair (NER) is a functionally conserved repair system which is 
present in prokaryotes, archaea, and eukaryotes. NER can deal with a large variety of 
chemically and structurally unrelated helix-distorting DNA lesions.  
However, transcribing RNA polymerase frequently encounters DNA damage, before it has 
been repaired, and the transcription machinery becomes arrested. Arrested RNA 
polymerase is a severe thread to the cell, as it can neither resume transcription elongation 
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nor dissociate from the template DNA by itself. It therefore prevents replication, 
transcription and repair of this gene. 
DNA damage in the transcribed strand of active genes is repaired by a special mode of 
NER, called transcription-coupled repair (TCR). In prokaryotes, TCR is mediated by the 
Mfd (mutation frequency decline) protein. Mfd releases arrested transcription elongation 
complexes, followed by delivery of the UvrABC nucleotide excision repair machinery to 
the lesion site. The mechanistic details of this process, however, are still poorly 
understood. 
 
Aim of this PhD thesis was to gain insight into the mechanism of bacterial transcription-
coupled repair.  
Knowledge of their three-dimensional structure can provide important information on the 
biological function of proteins, and on their mode of operation. Therefore, X-ray 
crystallography should be used in order to obtain structural information on the Escherichia 
coli Mfd protein.  
Furthermore, the protein should be characterized in a functional way. In particular, the 
interaction between Mfd and the nucleotide excision repair protein UvrA was investigated. 
UvrA-binding is mediated by the N-terminus of Mfd, and is required for recruitment of the 
NER machinery.  
The major objective of these studies was to reveal new aspects of this important event 
during transcription-repair coupling in order to suggest a possible mechanism for this 
recruitment step. 
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2 Materials and methods 
 
2.1 Materials 
All common chemicals were reagent-grade reagents purchased from Merck (Darmstadt, 
Germany), Sigma (Deisenhofen, Germany) or Carl Roth (Karlsruhe, Germany), unless 
otherwise stated. Crystallization screens and crystallization tools were from Hampton 
Research (Aliso Viejo, USA), Nextal Biotechnologies (Montreal, Canada; now QIAGEN, 
Hilden, Germany) or Jena Bioscience (Jena, Germany). RP-HPLC purified 
oligonucleotides were ordered from Thermo Electron Corporation (Ulm, Germany). 
Enzymes and nucleotides for molecular biology were from Fermentas (St- Leon-Rot, 
Germany). 
 
2.2 Molecular biology methods 
Common molecular biology procedures like polymerase chain reaction (PCR), cleavage of 
phosphodiester bonds in DNA by restriction endonucleases, dephosphorylation of DNA 
ends by alkaline phosphatase, ligation of DNA ends, amplification of plasmid DNA and 
agarose gel electrophoresis were carried out according to standard protocols (Sambrook, 
1989).  
 
Bacterial genomic DNA was prepared with DNAzol® reagent (Molecular Research 
Center, Cincinnati, USA) according to the manufacturer's instructions. Plasmid DNA was 
isolated using the NucleoSpin®-Plasmid Quick Pure Kit (Macherey-Nagel, Dueren, 
Germany). DNA fragments were extracted from agarose gels with the NucleoSpin®-
Extract II Kit (Macherey-Nagel, Dueren, Germany). DNA-sequencing was performed by 
Medigenomix (Martinsried, Germany). 
 
2.2.1 Cloning 
Genes of interest were amplified by PCR from Escherichia coli K12 (XL1-Blue) genomic 
DNA with ACCUZYME™ DNA polymerase (Bioline, Luckenwalde, Germany) and 
cloned into the pET-21b, pET-28b or pET-29b vectors (both from Novagen, 
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Schwalbach/Ts., Germany) or the pTYB1 vector (New England Biolabs, Frankfurt/Main, 
Germany) according to table 2.3. Oligonucleotides used as PCR-primers were designed 
using GeneRunner (http://www.generunner.com/). 
 
Table 2.1:  List of oligonucleotides used for cloning. Underlined regions mark the 
recognition sites for restriction endonucleases. Sequences are given in 
5'-3' direction. 
Oligo name Sequence 
Mfd N0 for NheI  AAAAGCTAGCATGCCTGAACAATATCGTTATACGC 
Mfd N0 for NdeI  AAAACATATGCCTGAACAATATCGTTATACGC 
Mfd C0 rev NotI AAAAGCGGCCGCAGCGATCGCGTTCTCTTCC 
Mfd N333-STOP rev NotI TTTTTGCGGCCGCCTAGTTTTTCAGCTCTGAGAAGAGC 
Mfd N333 rev NotI TTTTTGCGGCCGCGTTTTTCAGCTCTGAGAAGAGC 
Mfd N433-STOP rev NotI AAAAAGCGGCCGCCTAACCATGTTCGGCAGCGCC 
Mfd N433 rev NotI AAAAGCGGCCGCACCATGTTCGGCAGCGCC 
Mfd D586-STOP rev NotI TTTTGCGGCCGCCTAATCGTGTTTAAACGCGAAGCCCTC 
Mfd D586 rev NotI TTTTGCGGCCGCATCGTGTTTAAACGCGAAGCCCTC 
Mfd S964 for NdeI AAAAACATATGAGCGGCTCAATGGAAACCATCGG 
UvrA N0 for NdeI AAAAACATATGGATAAGATCGAAGTTCGGGG 
UvrA C0 rev XhoI AAAAACTCGAGCAGCATCGGCTTAAGGAAGCG 
UvrB N0 for NdeI AAAAACATATGAGTAAACCGTTCAAACTGAATTCC 
UvrB G583 rev HindIII AAAAAAAGCTTTCCGTGTTCCTCGTTGTACTTCTGC 
 
 
2.2.2 Site-directed mutagenesis  
Point mutations were introduced by PCR-based site-directed mutagenesis (Ho et al., 1989). 
Complementary oligonucleotides containing the desired mutation were used in a first PCR. 
In this reaction, two PCR-products with overlapping ends were generated.  
These DNA fragments were used as templates in a subsequent reaction, the overlap 
extension. Here, the overlapping ends were annealed, allowing a 3'-extension of the 
complementary strand. After 3 cycles, the flanking primers were added, and the fusion 
product was further amplified by PCR. 
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Table 2.2: List of oligonucleotides used for site-directed mutagenesis. 
Complementary regions are underlined, nucleotides coloured in blue 
correspond to the mutated codons. Sequences are given in 5'-3' 
direction. 
Desired mutation Sequences (forward / reverse primers) 
Mfd R165A 
CACGGCGGGCGCGTTGCTGGATCTCTTCC 
CGCGCCCGCCGTGGCGTATTCGCCGTGC 
Mfd R181A 
GCTGCCTTATGCGCTTGATTTCTTTGATGATGAAATC 
CAAAGAAATCAAGCGCATAAGGCAGCTCACTCCCCATCG 
Mfd R181A/D183A 
GCTGCCTTATGCGCTTGCGTTCTTTGATGATGAAATCGACAGC 
CAAAGAACGCAAGCGCATAAGGCAGCTCACTCCCCATCG 
Mfd F185A 
CGTCTTGATTTCGCGGATGATGAAATCGACAGCCTGC  
CATCATCCGCGAAATCAAGACGATAAGGCAGC 
Mfd E188A 
CTTTGATGATGCAATCGACAGCCTGCGGGTG 
GGCTGTCGATTGCATCATCAAAGAAATCAAGACG 
Mfd D190A  
GATGATGAAATCGCGAGCCTGCGGGTGTTTGACG 
GCAGGCTCGCGATTTCATCATCAAAGAAATCAAGACG 
Mfd ∆2 (AA 124 – 213) 
CCACGGTCATGGCACTAGTTCCCCCGCGCACGAATTTCCG 
GGAACTAGTGCCATGACCGTGGAGAAAACTGTGTGG 
Mfd C118A 
CTGTGTGGGGCAACACGTTGCATAAGCGTATTCACCGGAACAATC
GCAACGTGTTGCCCCACACAGTTTTCTCCACGG 
Mfd C445A 
GATCGCTTTCGGCAATCAGCGCCAGATTACGC 
GCTGATTGCCGAAAGCGATCTGCTCGGTG 
 
 
Table 2.3: Expression plasmids 
# 
Insert 
(construct) 
Vector Restriction sites Tag Remarks 
1 
Mfd (WT) 
full-length 
pET-21b NheI/NotI –  
2 
Mfd (WT) 
full-length 
pET-21b NheI / NotI C-HIS "Mfd-FL" 
3 
Mfd (WT) 
AA 1 – 333 
pET-21b NdeI / NotI – "Mfd-N1" 
4 
Mfd (WT) 
AA 1 – 333 
pET-21b NdeI / NotI C-HIS6 "Mfd-N2" 
5 
Mfd (WT) 
AA 1 – 433 
pET-21b NdeI / NotI – "Mfd-N3" 
6 
Mfd (WT) 
AA 1 – 433 
pET-21b NdeI / NotI C-HIS6 "Mfd-N4" 
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7 
Mfd (WT) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-N5" 
8 
Mfd (WT) 
AA 1 – 586 
pET-21b NdeI / NotI C-HIS6 "Mfd-N6" 
9 
Mfd (WT) 
AA 964-1148 
pET-21b NdeI / NotI – "Mfd-C1" 
10 
Mfd (WT) 
AA 964-1148 
pET-28b NdeI / NotI N-HIS6 "Mfd-C2" 
11 
UvrA (WT) 
full-length 
pTYB-1 NdeI / XhoI C-INTEIN  
12 
UvrA (WT) 
full-length 
pET-29b NdeI / XhoI C-HIS  
13 
UvrB (WT) 
AA 1 – 583 
pET-21b NdeI / HindIII C-HIS "UvrB-N" 
14 
Mfd (R165A) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-Mut1" 
15 
Mfd (R181A) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-Mut2" 
16 
Mfd (R181A/D183A) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-Mut3" 
17 
Mfd (F185A) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-Mut4" 
18 
Mfd (E188A) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-Mut5" 
19 
Mfd (E190A) 
AA 1 – 586 
pET-21b NdeI / NotI – "Mfd-Mut6" 
20 
Mfd (WT) 
AA 1 – 123 / 214 – 586  
pET-21b NdeI / NotI – "Mfd-∆2" 
21 
Mfd (C118A/C445A) 
AA 1 – 586 
pET-21b NdeI / NotI – "CYS-DM" 
 
 
2.3 Microbiology methods 
 
Bacteria were grown in shaking cultures in liquid LB medium or on LB agar plates 
containing the appropriate antibiotics. For storage, cells were kept in 40 % glycerol at 
-80°C. 
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Table 2.4:  Bacterial Strains 
Strain Genotype Source 
XL1-Blue  recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F'proAB lacIqZ∆M15 Tn10 (TetR)] 
Stratagene,  
La Jolla, USA 
Rosetta (DE3) F
– ompT hsdSB (rB– mB–) gal dcm lacY1 (DE3) 
pRARE (CmR) 
Novagen, Schwalbach/Ts., 
Germany 
B834 (DE3) 
F– ompT hsdSB (rB– mB–) gal dcm met (DE3), 
transformed with pRARE (CmR) isolated from 
Rosetta (DE3) cells 
Novagen, Schwalbach/Ts., 
Germany 
 
 
Table 2.5:  Composition of Luria-Bertani (LB)-broth (Miller, 1972) 
Bacto-Tryptone  1.0 % (w/v) 
Yeast-Extract   0.5 % (w/v) 
NaCl   1.0 % (w/v) 
pH 7.0 
 
1.5–2 % (w/v) of Bacto-Agar were added to the medium to prepare LB-agar plates. 
 
 
Table 2.6:  Antibiotics and supplements 
Supplement stock solution in media 
Ampicillin 100 mg/ml (H2O) 100 µg/ml 
Chloramphenicol 34 mg/ml (Ethanol) 34 µg/ml 
Kanamycin 50 mg/ml (H2O) 50 µg/ml 
Tetracycline 10 mg/ml (Ethanol) 10 µg/ml 
IPTG 0.5 M (H2O) 0.15 mM 
 
 
2.3.1 Transformation of E.coli 
Buffer TfBI       Buffer TfBII 
30 mM potassium acetate pH 5.8   10 mM MOPS pH 7.0 
100 mM KCl      10 mM KCl 
50 mM MnCl2     75 mM CaCl2 
10 mM CaCl2      15% Glycerol  
15% Glycerol  
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The preparation of transformation competent bacteria according to (Hanahan, 1983) was 
conducted by successive incubations in buffers TfBI and TfBII on ice. Aliquots of cells in 
TfBII were snap-frozen in liquid nitrogen and stored at -80°C. 
For transformation ca. 100 ng of ligated DNA or 10 ng of plasmid DNA were added to 75 
µl of competent cells. Cells were incubated on ice for 20 minutes, and a heat step at 42°C 
was carried out for 45-60 seconds. After addition of 800 µl of LB medium, cells were 
incubated for 45-60 minutes at 37°C. The suspension was plated on LB-agar plates 
containing the corresponding antibiotics and incubated over night at 37°C. 
 
2.3.2 Protein expression 
Proteins were overexpressed recombinantly in E.coli Rosetta (DE3) cells.  
Competent cells were transformed with plasmids containing the gene of interest. Cells 
were grown in LB medium supplemented with the corresponding antibiotics at 37°C. At an 
OD600 of 0.4-0.6, the cultures were cooled down to 18°C. Gene expression was induced by 
addition of 0.15 mM IPTG, and protein production was carried out overnight at 18°C. 
Cells were harvested by centrifugation and snap-frozen in liquid nitrogen. Cell pellets were 
stored at -80°C.  
 
2.3.3 Selenomethionine-labelling 
Selenomethionine-substituted protein was produced using the methionine auxotrophic 
B834 (DE3) strain. Cells were transformed with the pRARE (CmR) plasmid isolated from 
the Rosetta (DE3) strain, and with a plasmid containing the gene of interest. 
 
Cells were grown in LB medium containing the appropriate antibiotics at 37°C to an OD600 
of 0.4. Bacteria were harvested and resuspended in the same amount of LeMaster’s 
medium containing selenomethionine (table 2.7) (LeMaster and Richards, 1985). 
Appropriate antibiotics were added.  
Cells were grown at 37° C for one generation time to deplete the medium of residual 
methionine. The cultures were cooled on ice, and protein expression was induced by the 
addition of 0.15 mM IPTG. Selenomethionine-containing protein was produced over night 
at 18° C. The modified protein was purified as described above. 1 mM DTT was added to 
each buffer to prevent oxidation of selenomethionine. 
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Table 2.7:  LeMaster’s medium (LeMaster and Richards, 1985) 
autoclavable portion A for LeMaster’s medium (g / 2000 ml) 
alanine    1.0  serine     4.166  
arginine hydrochloride    1.16  threonine     0.46  
aspartic acid     0.8  tyrosine     0.34  
cystine    0.066  valine     0.46  
glutamic acid    1.5  adenine     1.0  
glutamine     0.666  guanosine     1.34  
glycine     1.08  thymine     0.34  
histidine     0.12  uracil     1.0  
isoleucine     0.46  sodium acetate    3.0  
leucine     0.46  succinic acid     3.0  
lysine hydrochloride    0.84  ammonium chloride    1.5  
phenylalanine     0.266  sodium hydroxide     1.7  
proline     0.2  dibasic potassium phosphate  21.0 
 
All amino acids were reagent-grade L-enantiomers purchased from Sigma (Deisenhofen, 
Germany). 
 
After autoclaving of solution A, the solution was cooled down to 37°C. Subsequently, 
filter-sterilized solution B (200 ml of solution B / 2000 ml of solution A) was added. 
 
non-autoclavable solution B 
glucose 20.0 g  
magnesium sulfate heptahydrate   0.5 g 
iron sulfate   8.4 mg 
sulfuric acid (concentrated) 16.0 µl 
thiamin 10.0 mg 
 
 
Selenomethionine (Calbiochem, Schwalbach/Ts., Germany) was dissolved in sterile H2O 
and added to the medium (100 mg / 2200 ml). 
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2.4 Proteinchemical methods 
Physical and chemical parameters like molecular weight, (theoretical) isoelectric point (pI), 
extinction coefficient etc. for the recombinant proteins were calculated with the ProtParam 
Tool (Gasteiger et al., 2003) from the ExPASy Proteomics Server 
(http://www.expasy.org/). Protein secondary structure prediction was carried out by the 
PSIPRED Protein Structure Prediction Server (http://bioinf.cs.ucl.ac.uk/psipred/) (Jones, 
1999; McGuffin et al., 2000; Bryson et al., 2005). Sequence alignment was performed with 
ClustalW (http://align.genome.jp/) and edited manually using GeneDoc (Nicholas and 
Nicholas, 1997) 
 
2.4.1 Protein purification 
Buffer Ni2+-A1 
50 mM NaH2PO4 pH 8.0  
200 mM NaCl  
 
Buffer Ni2+-A2 
50 mM NaH2PO4 pH 8.0  
200 mM NaCl  
10 mM imidazole 
 
Dilution Buffer  
20 mM TRIS/HCl pH 8.0 
1 mM EDTA  
10 % Glycerol  
 
Size Exclusion Buffer  
20 mM TRIS/HCl pH 8.0  
200 mM NaCl  
0.1 mM EDTA  
1 mM DTT  
 
Buffer Ni2+-HS 
50 mM NaH2PO4 pH 8.0  
2 M NaCl  
 
Buffer Ni2+-B 
50 mM NaH2PO4 pH 8.0  
200 mM NaCl  
250 mM imidazole 
 
SourceQ Buffer  
20 mM TRIS/HCl pH 8.0  
50 – 500 mM NaCl  
0.1 mM EDTA 
 
 
 
 
 
 
Cell pellets were resuspended in buffer Ni2+-A1 supplemented with 200 µM PMSF and 
disrupted by sonification. The lysate was cleared by centrifugation and loaded onto 
Ni2+-NTA column (QIAGEN, Hilden, Germany) pre-equilibrated with Ni2+-A1. The 
column was washed subsequently with buffers Ni2+-HS and with Ni2+-A2. Buffer Ni2+-B 
was used for protein elution. Elution fractions were analyzed using the Bio-Rad's protein 
assay (Bio-Rad, Munich, Germany), and protein-containing fractions were pooled. 
 Materials and methods 28 
After dilution with dilution buffer 1:5, the eluate was loaded onto a Resource Q anion 
exchange column (Amersham Bioscience, Freiburg, Germany) equilibrated with SourceQ 
buffer containing 50 mM NaCl. The protein was eluted with a linear gradient of 10 column 
volumes from 50 mM to 500 mM NaCl in the same buffer. Peak fractions were pooled, 
and, after concentration, applied onto a Superdex 200 size-exclusion column (Amersham 
Bioscience, Freiburg, Germany). Peak fractions were pooled and concentrated to the 
desired concentration. 
 
2.4.2 Protein-protein interaction assay 
Lysis Buffer 
50 mM NaH2PO4 pH 8.0 
100 mM NaCl 
 
Wash Buffer  
50 mM NaH2PO4 pH 8.0 
100 mM NaCl 
10 mM imidazole 
 
High Salt Buffer  
50 mM NaH2PO4 pH 8.0 
1 M NaCl 
 
Elution Buffer  
50 mM NaH2PO4 pH 8.0 
100 mM NaCl 
 250 mM Imidazol 
The interaction of UvrA with Mfd mutants was analyzed analogously to Truglio et al., 
2004. In a first step, UvrA was immobilized on agarose beads. Subsequently, Mfd mutants 
were added in excess, and the resin was washed gently in order to avoid disruption of the 
salt-sensitive complexes. Proteins were eluted and analyzed by SDS-PAGE. 
As a first step, full-length UvrA was coupled to Ni2+-NTA agarose beads (QIAGEN, 
Hilden, Germany) via its C-terminal hexahistidine tag. Cells from 600 ml expression 
culture were resuspended in lysis buffer containing 200 µM PMSF. They were lysed by 
sonification, and the lysate was cleared by centrifugation. The supernatant was mixed with 
1 ml of Ni2+-NTA resin and rotated end-over-end for 2 h at 4°C. The resin was washed 
successively with lysis buffer, high salt buffer and wash buffer. After re-equilibration with 
lysis buffer, the resin was distributed to 8 Poly-Prep Chromatography Columns (Bio-Rad, 
Munich, Germany).  
For the interaction analysis, lysates from cells expressing untagged mutants of Mfd-N5 
(residues 1-586) were added to the resin. Cells fom 200 ml expression culture were each 
resuspended in lysis buffer containing 200 µM PMSF and lysed by sonification. The 
obtained lysates were cleared by centrifugation, and each lysate was added to one of the 
UvrA-Ni2+-columns and allowed to flow through the resin. The columns were washed 
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successively with lysis buffer and wash buffer. Elution buffer was used for protein elution. 
Protein-containing elution fractions were determined using the Bio-Rad's protein assay 
(Bio-Rad, Munich, Germany), and complexes of UvrA and Mfd-N5 were analyzed by 
SDS-PAGE. Scanned gels were evaluated using the Image J software 
(http://rsb.info.nih.gov/ij/).  
 
Parts of this assay were carried out by Gabriela Guédez-Rodriguez, a Master of 
Biochemistry student at the University of Munich, Germany. 
 
2.5 Protein analysis 
2.5.1 Analytical size exclusion chromatography 
Size Exclusion Buffer  
20 mM TRIS/HCl pH 8.0  
200 mM NaCl  
0.1 mM EDTA  
1 mM DTT  
 
In order to determine the molecular weight of proteins, analytical gel filtration was 
performed using a Superdex 200 10/300 GL column (Amersham, Freiburg, Germany). The 
column was calibrated using the Gel Filtration Standard (Bio-Rad, Munich, Germany) in 
the same buffer. 
 
2.5.2 Limited proteolysis 
In order to discriminate between stable and flexible regions within a protein of interest, 
limited proteolysis was performed. The reaction was carried out in size exclusion buffer in 
a total volume of 50 µl.  
30 µg of purified protein were incubated with different amounts of Proteinase K 
(Fermentas St- Leon-Rot, Germany) (0.005/0.05/0.5/5 µg) for 45 minutes at room 
temperature. The reaction was stopped by addition of 2 µl of PMSF (saturated solution in 
2-propanol). Proteolytic digest was also carried out in the presence of 20 µM Adenosine 5′-
[γ-thio]triphosphate (ATP-γ S, Sigma, Deisenhofen, Germany) and 20 µM ATP-γ-S plus 
20 µM DNA (dsHOL-1), respectively. 1 mM MgCl2 were added to the reaction buffer. 
 
 Materials and methods 30 
-dsHOL-1: 5'-GGCGACGTGATCACCAGATGATGCTAGATGCTTTCCGAAGAGAGAGC 
           CCGCTGCACTAGTGGTCTACTACGATCTACGAAAGGCTTCTCTCTCG-3' 
 
2.5.3 Denaturing polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were analyzed by SDS-PAGE (Laemmli, 1970) using the vertical Mini-
PROTEAN 3 System (Bio-Rad, Munich, Germany). Protein bands were stained with 
Coomassie Brilliant Blue R-250 (Carl Roth, Karlsruhe). Bands of interest were excised 
from the gel using sterile disposable scalpels and analyzed by EDMAN-sequencing and/or 
mass spectrometry. 
2.5.4 Protein sequencing (Edman, 1950) 
For N-terminal sequencing, proteins were blotted onto a piece of PVDF membrane by 
passive adsorption. 
Excised bands were dried in a Speed-Vac and, after drying, reswollen in 35µl of 200 mM 
TRIS/HCl pH 8.5, 2 % SDS. After swelling, a concentration gradient was set up by 
addition of 150 µl of distilled water. A small piece of PVDF membrane (Carl Roth, 
Karlsruhe, Germany) was activated in methanol and added to the gel band. Once the 
solution started to turn blue, 20 µl of methanol were added. 
After 1-2 days, the solution had become clear and the membrane had turned blue. The 
membrane was washed 5 times with 1ml of 10 % Methanol with vortexing for 30 seconds 
each time.  
After air drying, the protein was N-terminally sequenced from the membrane in a 
PROCISE 491 sequencer (Applied Biosystems, Darmstadt, Germany). The sequencing 
reaction was carried out by Stefan Benkert (Gene Center, Munich, Germany). 
 
2.5.5 Matrix assisted laser desorption ionisation Time-of-Flight 
analysis  
For mass spectrometric analysis, protein bands of interest were tryptically digested. The 
obtained peptides were crystallized on a sample plate using an organic matrix and analyzed 
by Matrix-assisted laser desorption ionisation - Time-of-Flight (MALDI-ToF) mass 
spectrometry (MS). 
Tryptic digest was performed using a modified protocol for the Montage In-Gel Digest 96 
Kit (Millipore, Billerica, USA) (J. Rauch, personal communication). 
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Excised protein bands were cut into 1x1 mm pieces and transferred to 1.5 ml Eppendorf- 
tubes (Eppendorf AG, Hamburg, Germany: #3810). Bands were washed with ultrapure 
water from a Milli-RO 60 water purifying system (Millipore GmbH, Schwalbach/Ts., 
Germany) and twice alternately with 100% acetonitrile (ACN) and 50 mM ammonium 
bicarbonate. After washing with with 50% acetonitrile, the proteins were digested each 
with 3 µg of sequencing grade modified porcine trypsin (Promega, Mannheim, Germany) 
in 30 µl 50 mM ammonium bicarbonate over night at 30°C. 
The gel pieces were incubated twice with 100 µl of 75% ACN, 12.5 mM ammonium 
bicarbonate for 30 minutes in order to extract the peptides from the gel. The extracts were 
pooled, and the obtained peptide mixtures were concentrated in a Speed-Vac. 
Lyophilized peptides were resolved in 10 µl 0.1 % of trifluoroacetic acid (TFA) and mixed 
1+1 with freshly prepared matrix solution. 1 µl was spotted on a matrix assisted laser 
desorption ionization (MALDI) AnchorChip sample plate (Bruker Daltonik, Bremen, 
Germany). 
Peptide mass fingerprinting analysis was performed on a Bruker Reflex III MALDI-ToF 
mass spectrometer (Bruker Daltonik, Bremen, Germany) by Jens Rauch (Klinikum 
Grosshadern, Munich, Germany) and Thomas Knöfel (GSF, Munich, Germany). The list of 
peptide masses was aligned with the MASCOT Search Engine 
(http://www.matrixscience.com) using the SwissProt Database. 
 
-Matrix solution: α-cyano-4-hydroxycinnamic acid (CHCA) (Bruker Daltonik, Bremen, Germany) 
prepared as a saturated solution in 50% ACN, 0.1% TFA 
 
2.6 Functional assays 
2.6.1 ATPase activity assay 
ATPase Buffer  
40 mM HEPES, pH 7.8 
100 mM KCl  
8 mM MgCl2  
4% Glycerol  
5 mM DTT 
 
ATPase activity was tested by thin layer chromatography (TLC).  
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5 µM of purified protein were incubated with 10 µM ATP (containing 1/3000 Redivue 
γ32P-ATP (Amersham Biosciences, Freiburg, Germany)) at 37°C for 20 minutes in a total 
volume of 20 µl. ATPase activity was determined in the absence and in the presence of 
50 µM (10-fold excess) of dsDNA (dsHOL-1). 
Aliquots of 1 µl were spotted on a polyethyleneimine (PEI) cellulose plate (MERCK, 
Darmstadt, Germany). TLC plates were developed in 0.5 M LiCl, 1 M formic acid, dried 
and analyzed with a STORM Phosphor-Imager and ImageQuant Software (both Amersham 
Biosciences, Freiburg, Germany).  
The upper spot corresponds to liberated γ-32P and the lower spot to non-hydrolyzed ATP. 
 
-dsHOL-1: 5'-GGCGACGTGATCACCAGATGATGCTAGATGCTTTCCGAAGAGAGAGC 
           CCGCTGCACTAGTGGTCTACTACGATCTACGAAAGGCTTCTCTCTCG-3' 
 
2.6.2 DNA binding assay  
Annealing Buffer     Binding buffer  
100 mM TRIS/HCl pH 7.5    40 mM HEPES, pH 7.8  
100 mM NaCl     100 mM KCl  
10 mM MgCl2     8 mM MgCl2  
1 mM DTT     4 % Glycerol  
5 mM DTT  
1xTB Buffer      100 µg/ml BSA  
90 mM TRIS      2 mM ATP-γ-S 
90 mM boric acid 
 
DNA binding activities of Mfd constructs were analyzed using the electrophoretic mobility 
shift assay (EMSA). Complexes of protein and DNA migrate through a native 
polyacrylamide (PAA) gel more slowly than free oligonucleotides. 
One DNA strand was radioactively labelled. 5'-labelling of single stranded DNA was 
performed using T4 polynucleotide kinase (PNK) (Fermentas, St- Leon-Rot, Germany) 
according to manufacturer's instructions with Redivue γ32P-ATP (Amersham Biosciences, 
Freiburg). Unincorporated radionucleotides were removed using the Nucleotide Removal 
Kit (QIAGEN, Hilden, Germany). In order to generate dsDNA, two complementary 
oligonucleotide strands were annealed. 
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The gel shift assay was performed using a modified protocol according to (Selby and 
Sancar, 1995a). 
Proteins were incubated in binding buffer for 20 minutes on ice. Labelled dsDNA was 
added, and the samples were incubated for further 20 minutes at 4°C.  
The final concentration of the oligonucleotides was 0.2 nM, proteins were each present at 
1.5 µM in a total reaction volume of 20 µl. 
In order to separate free probe from protein-bound polynucleotide, 15 µl from the binding 
reaction were analyzed a on a native 6% polyacrylamide gel in 0.2x TRIS-borate (TB) 
buffer. After gel drying on a Model 583 Gel Dryer (Bio-Rad, Munich, Germany), 
radioactivity was recorded with the STORM Phosphorimager (Amersham Biosciences, 
Freiburg, Germany). The lower visible band corresponds to protein-free probe, the upper 
band to the shifted protein-bound oligonucleotide. 
 
-dsDNA-1: 5'-AAAAGCAAATTGCCTT-3' 
       3'-TTCGTTTAACGG-5' 
 
dsDNA-2: 5'-AAAAGCAAATTGCCGAAGACGAACGCGTT-3' 
         3'-TTCGTTTAACGGCTTCTGCTTGCGC-5' 
 
2.7 Structural analysis of Mfd-N2 
2.7.1 Protein crystallization by sitting drop vapour diffusion 
In order to determine the three-dimensional structure of a molecule by X-ray diffraction, 
high quality crystals are required. X-ray scattering from one molecule in solution would 
not generate a signal strong enough for detection. In a crystal, the molecule of interest is 
periodically repeated, all molecules having the same relative position and orientation. If 
scattered waves from these molecules interfere in a constructive manner, they give rise to a 
diffraction pattern (see 1.2.3).  
The quality of a crystal is influenced by many parameters like structural flexibility, solvent 
content, impurities, defects in the crystal lattice, mosaicity etc. The shape and size of a 
crystal also play an important role in its diffraction properties.  
Typical crystals used in X-ray diffraction experiments have a size of 100-300 µm in all 
three dimensions. Today, strong synchrotron radiation also allows structure determination 
with smaller crystals. In this case, crystals with a size of 40 µm x 40 µm x 110 µm were 
sufficient.  
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Protein crystallization requires high amounts of pure and homogeneous protein. The 
protein is slowly concentrated to a supersaturated state. During this process, crystals may 
appear. There are several crystallization techniques, including microdialysis, batch 
crystallization, hanging drop or sitting drop vapour diffusion (for an overview see for 
example http://www.hamptonresearch.com/support/Growth101Lit.aspx). Today, the 
vapour diffusion techniques are the most popular ones. In this PhD thesis, crystals were 
grown by the sitting drop vapour diffusion method (figure 2.1). 
In this technique, crystallization reagent is given into the reservoir of a crystallization 
plate. Reservoir solutions typically consist of buffer solution, precipitant, and salt. A small 
droplet of concentrated protein sample mixed with reservoir solution is set on a platform in 
vapour equilibration with the reservoir. As the drop contains a lower reagent concentration 
than the reservoir, water vapour leaves the drop. Thereby, the protein drop is slowly 
concentrated to a supersaturated state. In most cases, the protein will form aggregates and 
precipitate out of solution. Under certain conditions, stable nuclei may form, and crystals 
growth may take place. 
 
 
 
 
 
 
 
Figure 2.1:  Principle of protein crystallization by sitting drop vapour diffusion 
(adopted from http://www.hamptonresearch.com).  
 
In order to find a condition where nucleation and crystal growth are favored over 
precipitation, many crystallization reagents need to be tested. For this purpose, commercial 
sparse matrix screens are available, e.g from Hampton Research (Aliso Viejo, USA), 
Nextal Biotechnologies (Montreal, Canada) (now QIAGEN, Hilden, Germany) or Jena 
Bioscience (Jena, Germany).  
In order to improve the size and quality of obtained crystals, initial crystallization 
conditions are subsequently modified. Common approaches are variations of drop size, 
protein concentration, pH and ionic strength of the reservoir solution, and the use of 
additives like alcohols, sugars or salts. 
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2.7.2 Crystallization of Mfd-N2  
Mfd-N2 was crystallized by sitting drop vapour diffusion methods using 96-well 
crystallization plates (Corning, Schiphol-Rijk, The Netherlands). 
Crystals of Mfd-N2 were obtained with 50 µl of reservoir solution containing 0.08 M 
sodium citrate pH 5.6, 0.16 M ammonium sulfate, 20% PEG-4000, 0.8 M sodium formate. 
After mixing 1 µl of protein solution (4 mg/ml in 20 mM TRIS/HCl, 200 mM NaCl, 0.1 
mM EDTA, 1 mM DTT) with 1 µl of reservoir solution, crystals appeared overnight at 
20°C.  
For initial crystal setups with commercial screens, the Hydra II semi-automatic protein 
crystallization robot (Matrix Technologies Apogent Discoveries, Hudson, USA) was used 
to set 0.5 + 0.5 µl drops. In order to improve size and quality of obtained crystals, initial 
crystallization conditions were refined manually. 1 + 1 µl drops were set in the same 
plates. The reservoir solution composition and reservoir volume as well as the protein 
concentration were varied. Screening of additives was performed as well. 
Crystals were transferred to mother liquid containing 20% PEG-400 and snap-frozen in 
liquid nitrogen. 
 
2.7.3 Data collection, structure determination, model building and 
refinement 
All diffraction data were collected at beamline ID14-4 (ESRF, Grenoble, France) with an 
ADSC Q4 CCD detector using ProDC (http://www.esrf.fr/computing/bliss/gui/prodc/). 
MOSFLM (Powell, 1999) was used to set up a data collection strategy in order to achieve 
high redundancy and completeness. Prior to data collection the optimal wavelengths for the 
MAD experiment were determined with a fluorescence scan on the selenium containing 
crystal. 
 
Data were processed with DENZO and SCALEPACK (Otwinowski and Minor, 1997) or 
with XDS and XSCALE (Kabsch, 1993). 
 
SOLVE (Terwilliger, 2002) was used to locate heavy atom sites, and phases were 
calculated with SHARP (de la Fortelle and Bricogne, 1997). Initial phases were improved 
with SOLOMON (Abrahams and Leslie, 1996). Automated and manual model building 
were carried out using ARP/wARP (Morris et al., 2003) and MAIN (Turk, 1992), 
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respectively. CNS v.1.1 (Brunger et al., 1998) was used for refinement. Coordinates as 
well as topology and parameter files for hetero-compounds were retrieved from the HIC-
Up server (Kleywegt and Jones, 1998). Stereochemistry of the final model was analyzed 
with PROCHECK (Laskowski et al., 1993). 
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3 Results 
 
3.1 Full-Length E.coli Mfd 
3.1.1 Purification and crystallization of full-length Mfd 
The gene encoding full-length Mfd was amplified from Escherichia coli XL1 Blue 
genomic DNA and cloned into the pET-21b vector (see table 2.3). The protein was 
recombinantly overexpressed in Rosetta (DE3) cells with a C-terminal HIS6-tag (“Mfd-
FL”). 
Mfd-FL was purified as described in 2.4.1. First, lysate from Mfd-FL-experssing cells was 
loaded onto a Ni2+-NTA column. The protein was further purified using a Resource Q 
anion exchange column and by size exclusion chromatography with a HiLoad 26/60 
Superdex 200 pg column (figure 3.1). 
Using this purification protocol, about 6 mg of highly pure and homogeneous protein could 
be obtained from 12 l of expression culture. Protein identity was confirmed by EDMAN-
sequencing. 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
Figure 3.1: Elution profile of Mfd-FL from the HiLoad 26/60 Superdex 200 pg size 
exclusion column. The major peak corresponds to purified Mfd-FL. 
SDS-PAGE analysis of the peak fractions is shown as inlet. 
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Crystallization setups were carried out with 5 mg/ml protein. No three-dimensional crystals 
could be grown. Using Nextal classic screen condition #34 (0.1 M tri-sodium citrate pH 
5.6, 0.2 M potassium/sodium tartrate, 2.0 M ammonium sulfate), bushes of needles were 
obtained. However, they were not reproducible and could not be improved. Without any 
tag, no better results were achieved (data not shown). 
 
 
 
 
 
 
 
 
Figure 3.2:  Crystals of Mfd-FL were obtained from Nextal classic screen condition 
#34 (0.2 M potassium/sodium tartrate, 0.1 M tri-sodium citrate pH 5.6, 
2.0 M ammonium sulfate) using 5 mg/ml protein.  
 
3.1.2 Limited proteolysis 
Highly mobile regions in proteins can inhibit crystallization. In order to identify those 
regions in Mfd, limited proteolysis was performed. Proteolysis of natively folded proteins 
occurs mainly at highly flexible parts, like loops, while globular domains are rather rigid 
and more resistant to proteolysis (Fontana et al., 1986; Fontana et al., 2004). Therefore, 
stable fragments in the proteolysis experiment may correspond to regions which are 
compact and hence serve as good candidates for crystallization.  
The protein was incubated with different amounts of Proteinase K under native conditions. 
Compared to other proteolytic enzymes, endopeptidase Proteinase K possesses broader 
substrate specificity as it cleaves peptide bonds after aliphatic, aromatic or hydrophobic 
amino acids. Thus, it is more likely to cleave within in a distinct region.  
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Figure 3.3: Limited proteolysis of Mfd-FL. From left to right: Cleavage pattern 
without ATP or DNA, with ATP, and with ATP and dsDNA. Bands 
marked with red boxes were analyzed by EDMAN-sequencing and mass 
spectrometry.  
 
Mfd contains a dsDNA translocase domain (residues 598-968) which is involved in DNA 
binding and ATP hydrolysis (Selby and Sancar, 1995a; Selby and Sancar, 1995b) (see 
1.1.2.3). Binding of ATP or DNA may lead to conformational changes in this module. 
Therefore, the experiment was also carried out in the presence of ATP-γ-S, a non-
hydrolyzable ATP analogon, and in the presence of ATP-γ-S and dsDNA, respectively. 
However, the addition of ATP-γ-S or dsDNA did not result in any detectable difference in 
the pattern (figure 3.3). In none of the experiments, stable fragment of this part could be 
found (see below). This indicates high flexibility in this region. 
 
Stable cleavage products (figure 3.3, red boxes) were analyzed by EDMAN-sequencing 
and peptide mass fingerprinting analysis. In peptide mass fingerprinting analysis, the 
fragments of interest were tryptically digested under denaturing conditions. Peptides were 
identified by MALDI-ToF mass spectrometry. As reference, Mfd-FL (band 0) was used. 
Mfd-FL could be identified in the SwissProt database using the MASCOT Search Engine. 
Sequence coverage of 48 % (556/1162) was achieved.  
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Figure 3.4: Stable regions of Mfd identified by limited proteolysis. While the N- and 
C-termini appeared rather stable, no fragments of the catalytic domain 
could be found. N- and C-terminal constructs are schematically shown. 
 
By mass spectrometry, only peptides in the range between 800 and 3300 Da were 
analyzed. Thus, peptides shorter than 8 residues were neglected. However, in some regions 
of Mfd, tryptic cleavage sites are located closer to each other. These peptides could not be 
detected in any of the samples. For instance, the N-terminal 40 residues were found in 
none of the samples, although EDMAN-sequencing of the full-length protein as well as of 
fragments 1-4 could identify the native N-terminus. Therefore, the list of identified 
peptides for a certain fragment was always compared with that for the full-length protein 
and/or longer fragments. 
A detailed list of peptides identified for each fragment can be found in the supplementary 
material (7.1). 
 
Bands 1-4 were found to be N-terminal fragments of 35 kDa (1), 50 kDa (2/4) and 60 kDa 
(3). Band 5 corresponds to the C-terminal 163 residues. No stable fragments of the 
catalytic domain could be found (figure 3.4).  
 
Based on these results, several N- and C-terminal constructs were cloned (table 3.1). For 
construct design, protein secondary structure prediction from the PSIPRED method (Jones, 
1999) was also taken into account. 
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Table 3.1:  N- and C-terminal constructs of E.coli Mfd which were designed based 
on the results of the limited proteolysis assay. 
construct no tag molecular 
weight 
with HIS6-tag molecular 
weight 
M1 – N333 "Mfd-N1" 38.1 kDa "Mfd-N2" 39.3 kDa 
M1 – N433 "Mfd-N3" 49.2 kDa "Mfd-N4" 50.5 kDa 
M1 – D586 "Mfd-N5" 66.1 kDa "Mfd-N6" 67.3 kDa 
S964 – A1148  "Mfd-C1" 21.4 kDa "Mfd-C2" 23.6 kDa 
 
 
3.2 Purification, crystallization and structure determination of 
Mfd-N2 
3.2.1 Purification of Mfd-N2 
For structure determination, an N-terminal construct of Mfd comprising the first 333 
residues of E.coli Mfd with a C-terminal hexahistidine tag ("Mfd-N2") was used.  
Mfd-N2 was purified as described in 2.4.1. Briefly, Mfd-N2 overexpressing Rosetta (DE3) 
cells were lysed by sonification, and the clarified lysate was loaded onto a Ni-NTA 
column. After elution, the protein was further purified by anion exchange chromatography 
using a Resource Q column, and by size exclusion chromatography on a HiLoad 16/60 
Superdex 200 pg column (figure 3.5). Peak fractions from the size exclusion were pooled. 
Protein was concentrated to 5 mg/ml and used for crystallization trials. From 6 l of 
expression culture, 20 mg of highly pure Mfd-N2 could be obtained. 
 
In the original purification protocol, elution fractions from the Ni2+-NTA column were 
directly applied to the size exclusion column. Crystals could be obtained from this protein 
batch, but they could not be reproduced or refined. Therefore, the anion exchange step was 
introduced between the affinity chromatography and the size exclusion column in order to 
further improve purity and homogeneity. 
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Figure 3.5:  Elution profile of Mfd-N2 from S200 16/60 size exclusion column 
(absorption at 280 nm, blue; absorption at 260 nm, pink). SDS-PAGE 
analysis of pooled and concentrated peak fractions is shown as insert.  
 
Other N-terminal constructs, "Mfd-N4" and "Mfd-N6" (table 3.1), were purified 
analogously. 
 
3.2.2 Crystallization 
For initial crystallization trials with commercial screens, a crystallization robot was used to 
set 0.5 + 0.5 µl drops with 50 µl reservoir volume in 96-well plates. First crystals were 
obtained with 5 mg/ml at 20°C. 
Small crystals with hexagonal morphology appeared over night in the crystallization 
conditions Hampton Index #6 (0.1 M TRIS/HCl pH 8.5, 2.0 M ammonium sulfate) and 
Jena Biosciences Screen 3 #C6 (0.1 M sodium citrate pH 5.6, 0.2 M ammonium sulfate, 
25% PEG-4000).  
 
20% PEG-400 was added as cryoprotectant and crystals were snap-frozen in liquid 
nitrogen. Diffraction to ~9 Å at beamline PX (SLS, Villingen, Switzerland) could be 
detected using crystals from the Jena Biosciences condition.  
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Figure 3.6:  Initial crystals of Mfd-N2 with a diameter of < 10 µm were obtained 
from A) Hampton Index reagent #6 (0.1 M TRIS/HCl pH 8.5, 2.0 M 
ammonium sulfate) and B) Jena Biosciences Screen 3 condition #C6 (0.1 
M sodium citrate pH 5.6, 0.2 M ammonium sulfate, 25% PEG-4000).  
 
For structure determination, crystal size and quality had to be improved. Therefore, 
refinements were set up by hand using the condition from the Jena Biosciences screen. A 
lower protein concentration of 4 mg/ml and a larger drop size of 1 + 1 µl (50 µl reservoir 
volume) gave slightly bigger crystals. Variation of the reservoir solution composition, 
however, did not result in any improvement compared to the original condition.  
Therefore, extensive additive screening was performed. 80 % (40 µl) of the initial 
crystallization condition (0.1 M sodium citrate pH 5.6, 0.2 M ammonium sulfate, 25% 
PEG-4000) were mixed with 20 % (10 µl) of a crystal screen reagent. Significantly bigger 
crystals could be observed when using condition #25 from Hampton Index (3.5 M sodium 
formate) or Nextal Classic condition #48 (4.0 M sodium formate) as additive.  
By variation of the formate concentration in the additive stock solution and the proportion 
between initial condition and additive, a final optimized crystallization condition was 
achieved. Using 0.08 M sodium citrate pH 5.6, 0.16 M ammonium sulfate, 20% PEG-
4000, 0.8 M sodium formate, crystals with a maximum size of 40 µm x 40 µm x 110 µm 
were obtained (figure 3.7). Selenium-containing crystals could be grown in the same 
conditions.  
A B
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Figure 3.7:  Refined crystals were obtained with 0.08 M sodium citrate pH 5.6, 0.16 
M ammonium sulfate, 20% PEG-4000 and 0.8 M sodium formate at 4 
mg/ml. Panel A) shows native crystals, B) shows a crystal of 
selenomethionine containing Mfd-N2. The crystals were of hexagonal 
morphology and had a diameter of ca. 40 µm. 
 
Crystals belonged to space group P6522 with unit cell constants of a=b=112.56 Å, 
c=213.50 Å, α=β=90° γ=120° (native crystal). The selenium containing crystals were 
isomorphous with a larger cell volume by only 0.3 %. 
The crystals showed an extremely low mosaicity of 0.24 (derivative, determined with 
DENZO) and 0.09, respectively (native, calculated by XDS). The asymmetric unit 
contained two molecules of Mfd-N2. This results in a solvent content of 50.45 % and a 
Matthews volume of 2.48 Å³/dalton of protein (Matthews, 1968; Kantardjieff and Rupp, 
2003).  
For data collection, crystals were transferred to reservoir solution supplemented with 20% 
PEG-400 and snap-frozen in liquid nitrogen.  
 
3.2.3 Data collection 
All diffraction data used for structure determination were collected at beamline ID14-4 
(ESRF, Grenoble, France) with an ADSC Q4 CCD detector. 140 images (1° oscillation 
each) were recorded for each dataset.  
 
A native dataset at 0.97395 Å was collected to 2.1 Å resolution. 
For phase determination, a three wavelength anomalous dispersion experiment was carried 
out at the selenium K edge using one selenium containing crystal. The optimal 
wavelengths were determined experimetally with a fluorescence scan (see figure 1.7). 
A B
A B 
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Datasets for the peak wavelength at 0.97788 Å (12678.23 kEV: f' -5.32, f'' 4.27) and the 
inflection point at 0.979804 Å (12653.96 kEV: f' -9.01, f'' 2.55) were collected to 2.6 Å. 
Due to radiation damage, diffraction data for the high remote wavelength at 0.97395 Å 
(12707.6 kEV: f' -4.17, f'' 4.00) could only be obtained to 2.8 Å.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8:  Diffraction image of Mfd-N2 recorded at beamline ID14-4 (ESRF, 
Grenoble, France). Native crystals diffracted to a resolution of 2.1 Å. 
 
3.2.4 Structure determination and refinement 
Anomalous data were processed with DENZO and SCALEPACK (Otwinowski and Minor, 
1997), while the native dataset was processed using XDS and XSCALE (Kabsch, 1993). 
Data were first indexed and scaled in space group P622. By means of systematic absences 
in the dataset (figure 3.9), the potential space groups could be limited to the 
enantiomorphous P6122 and P6522 (International Tables for Crystallography, Volume A: 
Space-group symmetry, 2002). The correct space group was P6522, which was revealed 
after map calculation with the two possible screw axes. 
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Figure 3.9:  A) Presentation of the native dataset (native.mtz) with hklview (CCP4) 
on section 0kl. Data was processed in space group P622. B) Zoomed 
section of A. On the l-axis (h=0, k=0), only every sixth reflection was 
present. This corresponds to a 61 or 65 screw axis. 
 
 
18 selenium sites could be located by SOLVE (Terwilliger, 2002). Initial phases were 
calculated with SHARP (de la Fortelle and Bricogne, 1997), and were improved by solvent 
flattening with SOLOMON (Abrahams and Leslie, 1996). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10:  Section of 1σ contoured MAD map at 2.8 Å resolution (blue mesh) with 
anomalous difference density contoured at 2.5 σ (white mesh). Six 
selenium atoms are shown as red spheres. 
 
A        B
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The resolution of 2.8 Å allowed automated model building. ARP/wARP (Morris et al., 
2003) built 567 out of 688 possible amino acids in the asymmetric unit. The model was 
completed manually with MAIN (Turk, 1992). After bulk solvent correction and 
anisotropic overall B-value correction, the model was refined against the 2.1 Å native data 
by rigid body refinement with CNS v.1.1 (Brunger et al., 1998). The refinement was 
continued by iterative cycles of simulated annealing, positional refinement and individual 
B-factor refinement with CNS, followed by manual model building with MAIN. Initial 
NCS restraints were gradually removed in the final cycles of the refinement.  
In the refined structure, 93.9% of the residues are found in the core of the Ramachandran 
plot, and none of the residues is found in a disallowed region (Laskowski et al., 1993).  
Data collection and model statistics are given in table 3.2. 
 
The final model comprised 617 residues of which 15 were present in two conformations 
(eight residues in molecule A, seven residues in molecule B). In addition, 440 water 
molecules, one sulphate and three sodium ions were detectable. Interestingly, also two 
PEG-400 molecules were visible in the density. PEG-400 was not present in the original 
crystallization reagent. It was used for cryoprotection. Crystals were transferred into PEG-
400 containing solution only for a few seconds directly before freezing. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11:  A) Zoomed section of 1σ contoured MAD electron density map (blue 
mesh) showing 4 antiparallel β-sheets. B) Exemplary experimental (2.8 
Å, upper panel) and final 2Fo-Fc (2.1 Å, lower panel) electron density 
maps. The final model is shown as colour-coded sticks. 
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Table 3.2: Crystallographic data collection and model refinement 
Crystal SeMet   native 
Space Group P65221   P65222 
Dataset peak inflection point high remote native 
Wavelength (Å) 0.97788 0.9798 0.97395 0.97395 
Data range (Å) 20.0-2.6 20.0-2.6 20.0-2.8 20.0-2.1 
Observations (unique) 416744 
(46059) 
417006 
(46109) 
259154 
(36731) 
1018169 
(47377) 
Completeness (%)  
(last shell) 
98.6 (96.8)3 98.6 (97.2)3 98.3 (96.5)3 99.5 (98.7) 
Rsym4 (last shell) 0.098 (0.273) 0.095 (0.271) 0.120 (0.324) 0.082 (0.362) 
Rmeas5 (last shell) 0.104 (0.290) 0.101 (0.287) 0.128 (0.344) 0.084 (0.372) 
I/σI (last shell) 23.0 (7.1) 19.6 (7.9) 16.8 (6.9) 33.9 (10) 
 
Refinement    native 
Data range (Å)    19.86-2.1 
Reflections F>0 (cross validation)    47432 
Protein atoms (solvent molecules)    5064 (442) 
Rwork6 / Rfree7 (%)    19.8 / 23.0 
rmsd bond length (Å) / bond angles (°)    0.0084 / 1.34 
Core (disallowed) in Ramachandran plot (%)    93.9 (0) 
 
1 unit cell (P6522) (Å/°): a=b=112.56 c=213.50 α=β=90 γ=120, two molecules per asymmetric unit 
2 unit cell (P6522) (Å/°): a=b=112.65 c=213.86 α=β=90 γ=120, two molecules per asymmetric unit 
3 anomalous completeness 
4 Rsym is the unweighted R value on I between symmetry mates 
5 Rmeas is the weighted R value on I between symmetry mates (Diederichs and Karplus, 1997). 
6 Rwork = ∑hkl║Fobs(hkl)│-│Fcalc(hkl)║/ ∑hkl│Fobs(hkl)│ for reflections in the working data set 
7 Rfree = ∑hkl testset║Fobs(hkl testset)│-│Fcalc(hkl testset)║/ ∑hkl│Fobs(hkl testset)│ for 5% of 
reflections against which the model was not refined 
 
 
Near the interface of the two molecules in the asymmetric unit, six methionine residues 
(three residues of each molecule) are located very close to each other (figure 3.10). The 
intramolecular distances between the sulfur atoms are in the range of 4-5 Å (table 3.3). 
Small distances between the heavy atoms in the selenium-containing crystal can cause 
difficulties in the separation of the anomalous peaks during phase determination. This may 
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explain why other phasing attempts, e.g. by SAD with SHELXD (Ness et al., 2004), had 
failed.  
 
Table 3.3:  Intramolecular distances between the sulfur atoms of methionine 
residues M66, M68, and M101. 
Methionine residues molecule A molecule B 
M66 – M68 4.19 Å 4.20 Å 
M66 – M101 4.20 Å 4.47 Å 
M68 – M101 4.89 Å 5.28 Å 
 
 
3.2.5 Mfd-N2 crystallized with two molecules in the asymmetric unit. 
One asymmetric unit contained two molecules of Mfd-N2 (figure 3.12). The two molecules 
were highly similar (RMSD of 0.93 Å). They shared a buried surface of 1834.19 Å² 
(Brunger et al., 1998). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12:  Mfd-N2 crystallized with two molecules in the asymmetric unit 
(molecule A, orange; molecule B, blue).  
 
According to literature, Mfd is functional as a monomeric protein (Selby and Sancar, 1993; 
Roberts and Park, 2004). In order to distinguish between a biological dimer and a 
crystallographic complex, analytical size exclusion chromatography using a Superdex 200 
10/300 GL column was performed (figure 3.13).  
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The retention volume of macromolecules from size exclusion columns depends on the 
hydrodynamic radius which corresponds to the (approximate) molecular weight for 
globular proteins. The column had previously been calibrated with a gel filtration standard. 
Thus, the apparent molecular weight (kDa) could be calculated by use of the retention 
volume (ml). 
From a retention peak volume of 15.17 ml, a molecular weight of 32.2 kDa could be 
calculated. This is consistent with the size of a monomer (39.3 kDa). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Analytical size exclusion chromatography of Mfd-N2 (absorption at 
280 nm, blue; absorption at 260 nm, pink). The retention volume of 
15.17 ml indicates that Mfd-N2 is monomeric.  
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3.3 Structure of Mfd-N2 
3.3.1 Mfd-N2 crystal structure  
Mfd-N2 is a triangular molecule of approximately 60 Å × 60 Å × 30 Å dimensions. It 
consists of three structural domains denoted domains 1A, 1B and 2 according to the UvrB 
nomenclature (Theis et al., 1999). Each domain forms one corner of the triangle 
(figure 3.14).  
Domain 1A (residues 26-70, 85-114, 266-286, 324-333, coloured orange in figure 3.14) 
contains both the N- and the C-terminus of Mfd-N2 and forms the structural framework of 
the molecule. A central parallel β-sheet (strands β1, β2, β3, β11) is sandwiched between 
two layers of α-helices (αA, αB and αC, αD, αK, αN). Domain 1A possesses the typical α/β 
fold of RecA-like ATPases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Ribbon presentation of Mfd-N2 with annotated secondary structure 
(α-helices, letters A-N; β-sheets, numbers 1-11). Mfd-N2 consists of 
three domains (domain 1A, orange; domain 1B, blue with loop, magenta; 
domain 2, green) that form a triangularly shaped structure.  
 
Domain 1B (residues 115-127, 212-265, 287-323, coloured in blue) is formed by three 
segments inserted into the primary sequence of domain 1A. Domain 1B is situated "on top" 
of domain 1A and is mainly α-helical. The body of domain 1B consists of two large 
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α-helical lobes, i.e. a helix-loop-helix protrusion (αL, αM) and a three helix bundle (αG, 
αH, αI). A prominent loop (residues 71-84, magenta in figure 3.14), joining β2 and αC of 
domain 1A, binds along the interface of the two α-helical lobes and completes domain 1B.  
Domain 1A and 1B form a structural unit. Domain 1B is assembled by three insertions into 
domain 1A. In addition, the two domains share an extensive, hydrophobic interface. 
Therefore, the mutual orientation of 1A and 1B appears rather stable.  
The compact globular domain 2 (residues 127–212, green in figure 3.14) is formed by a 
single insertion between helices αE and αG of domain 1B. Domain 2 is situated at the side 
of the interface of domains 1A and 1B. Domain 2 has a βαββββββ topology. A double 
layer of β-sheets packs on one side against a single α-helix (αF). The two antiparallel 
strands of the inner β-sheet (β4, β10) connect domain 2 to domain 1B. The five strands of 
the outer β-sheet (β5-β9) pack against this inner β-sheet and form a flat, slightly twisted 
solvent-exposed surface.  
In contrast to the intimate interaction of domains 1A and 1B, domain 2 appears less firmly 
attached. The interface of domain 2 with the remainder of Mfd-N2 is formed mainly by 
two loops, the loop between αF and β5 with domain 1B, and the loop between β6 and β7 
with αC of domain 1A. The two β-strands of the inner sheet covalently attach domain 2 to 
domain 1B. The interface between domain 2 and the remainder of Mfd-N2 is rather 
hydrophilic in nature. It contains a number of hydrogen bonds, but does not possess a large 
hydrophobic component. From a structural point of view, this interaction could allow some 
movement of domain 2.  
 
3.3.2 Conservation of the Mfd N-terminus 
Sequence conservation between Mfd proteins from different organisms was mapped onto 
the molecular surface of Mfd-N2 (figure 3.15). 
Two conserved surface patches on Mfd-N2 are revealed: One patch is formed by a loop 
located across the interface of domains 1A and 1B. This loop corresponds to the “β-
hairpin" motif in UvrB which functions in DNA binding in the nucleotide excision repair 
protein (see below) (Skorvaga et al., 2002; Truglio et al., 2006b). 
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Figure 3.15: Molecular surface of Mfd-N2 (oriented as in figure 3.14) with annotated 
structural domains. The colour coding corresponds to Mfd sequence 
conservation (dark red, conserved; white, unconserved). The most strongly 
conserved region of the Mfd N-terminus is the putative UvrA binding 
domain 2.  
 
The most strongly conserved region in Mfd-N2 is found on the surface of domain 2 (Selby 
and Sancar, 1993). Domain 2 is believed to function in UvrA-binding implicating a role of 
the conserved residues (Truglio et al., 2004). This would also be consistent with the strong 
conservation in domain 2 between Mfd and UvrB. Domain 2 will be discussed in more 
detail in chapter 3.3.4.  
 
3.3.3 Comparison of Mfd-N2 to UvrB 
Both in Mfd and UvrB, the N-terminal region functions in UvrA binding (Hsu et al., 1995; 
Selby and Sancar, 1995a; Truglio et al., 2004).  
By sequence comparison between UvrB and Mfd proteins, high homology was observed 
for domain 2 and, therefore, structural similarity has been proposed for this region (Selby 
and Sancar, 1993; Truglio et al., 2004). 
The structure and topology of Mfd-N2 was compared with the crystal structure of Bacillus 
caldotenax UvrB variant Y95A (PDB-ID 1T5L; Truglio et al., 2004) (figures 3.16 and 
3.18). Surprisingly, not only domain 2 is structurally similar to the corresponding part of 
UvrB. In fact, all three domains of Mfd-N2 resemble the fold and mutual arrangement of 
the three N-terminal domains of UvrB.  
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Figure 3.16:  Comparison of the Mfd-N2 structure with B.caldotenax UvrB (PDB-ID 
1T5L; Truglio et al., 2004). The orientation and colour coding is as in 
figure 3.14 (domain 1A, orange; domain 1B, blue with loop, magenta; 
domain 2, green; UvrB domain 3, grey).  
 
A sequence alignment of UvrB and Mfd N-terminal regions was generated with ClustalW 
(http://align.genome.jp/) and edited manually using GeneDoc (Nicholas and Nicholas, 
1997) based on B.caldotenax UvrB and E.coli Mfd-N2 crystal structures.  
The sequences of E.coli Mfd-N2 (residues 26-333) and the corresponding region of 
B.caldotenax UvrB (residues 45-390) have low pair-wise sequence identity of 17 %. 
However, high structural similarity (RMSD of 2.7 Å (Potterton et al., 2002; Potterton et 
al., 2004)) can be observed. 
 
 
Figure 3.17  (next page): Structure-based sequence alignment of Mfd and UvrB 
N-terminal regions. The secondary structure of Mfd-N2 is shown on top 
of the alignment and annotated according to figure 3.14. Conserved 
residues between Mfd and UvrB are shaded, dark indicating stronger 
conservation. Functional motifs mentioned in the text are boxed. 
Residues used in mutational studies are indicated with stars. 
Abbreviations: Eco, Escherichia coli; Bsu, Bacillus subtilis; Hin, 
Haemophilus influenza; Mtu, Mycobacterium tubercolosis. 
 
Mfd-N2              UvrB 
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Figure 3.18:  Toplogy diagrams of domains 1A, 1B and 2 of Mfd-N2 (left panel) and 
the corresponding domains of UvrB (right panel), using the color code 
and secondary structure annotation of figure 18. Walker A and B motifs 
of Mfd-N2 are indicated with quotation marks, because they are 
degenerated from the canonical sequences. 
 
Domain 1A of Mfd possesses the typical α/β fold of RecA-type ATPase domains and 
corresponds to the first RecA-like domain of UvrB. Domain 1B is more compact in Mfd 
than in UvrB but also shares the basic architecture. Interestingly, the β-hairpin that is 
implicated in DNA binding in UvrB is missing in Mfd (see 3.3.5.2). Domain 2, as expected 
from sequence similarity, is structurally very similar to UvrB domain 2 (see 3.3.4).  
However, while this domain by itself matches well, it is rotated with respect to domains 1A 
and 1B (figure 3.19). This was also found in the full-length E.coli Mfd structure 
(Deaconescu et al., 2006). As suggested above, the hydrophilic interface between domain 2 
and the remainder of Mfd-N2 might allow some movement of domain 2 with respect to 
domains 1A and 1B. The crystal structure of B.caldotenax UvrB mutant Y95A solved by 
Truglio and colleages was the first structure of an UvrB protein where domain 2 was 
clearly defined. In several other crystal structures of UvrB proteins, no clear electron 
density of domain 2 was visible (Machius et al., 1999; Nakagawa et al., 1999; Theis et al., 
1999; Truglio et al., 2004). This indicates a high mobility of domain 2 also in UvrB. 
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Figure 3.19:  Backbone worms of domains 1A, 1B and 2 of Mfd-N2 (colour code of 
figure 3.14) and B.caldotenax UvrB (light gray) superimposed on 
domains 1A and 1B. Domain 2 is rotated with respect to the remainder 
of the molecule. 
 
UvrB possesses a second RecA-like domain, domain 3 (coloured grey in figure 3.16). 
Together with domain 1A, domain 3 forms the ATP-dependent "helicase" motor in UvrB 
(Hsu et al., 1995). The corresponding region is missing in the Mfd-N2 construct. It was 
shown recently that Mfd does not possess an equivelent domain to UvrB domain 3 
(Deaconescu et al., 2006). 
 
3.3.4 Domain 2 
3.3.4.1 Superposition of domain 2 of Mfd and UvrB 
As shown above, the architecture of Mfd-N2 very much resembles that of UvrB. The 
region with the highest structural similarity between Mfd and UvrB was found to be 
domain 2. Residues 126-213 of E.coli Mfd superimpose well (RMSD of 1.35 Å) with 
domain 2 (residues 157–245) of B.caldotenax UvrB (figure 3.20).  
Domain 2 is the most conserved region of Mfd-N2 among Mfd proteins (see above). In 
addition, high sequence homology between Mfd and UvrB can be found (figure 3.17).  
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Figure 3.20:  Superposition of domain 2 of E.coli Mfd (grey) and B.caldotenax UvrB 
(white). This region is strongly conserved between Mfd and UvrB. 
 
3.3.4.2 Potential interaction sites 
Both in Mfd and UvrB, the N-termini function in UvrA binding. (Hsu et al., 1995; Selby 
and Sancar, 1995a; Truglio et al., 2004). In UvrB, this region could be further limited 
down to domain 2, which was shown to be essential for a productive UvrA-UvrB 
interaction in vitro (Hsu et al., 1995). Due to high sequence homology and structural 
similarity (see above), this is also expected to be true in Mfd (Truglio et al., 2006a). 
Many residues that are highly conserved between Mfd and UvrB cluster at the outside of 
the five-stranded twisted β-sheet of domain 2. Some of these residues in UvrB were found 
to be critical for the interaction with UvrA (Truglio et al., 2004). Most of these conserved 
residues possess a charged character which is consistent with the salt-sensitivity of the 
UvrA-UvrB/Mfd interaction (Selby and Sancar, 1993; Selby and Sancar, 1994; Hsu et al., 
1995; Truglio et al., 2004). 
An unusually solvent-exposed hydrophobic amino acid can be found at the "tip" of 
domain 2. This phenylalanine 185 is extremely conserved, and might function as an 
"anchor" in the complex. 
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Figure 3.21:  Molecular surface of Mfd domain 2 (orientation of figure 3.20). The left 
panel shows sequence conservation between Mfd and UvrB (dark red, 
conserved; white, unconserved), the conserved patch which is implicated 
to function in UvrA binding (see below) is encircled with a dotted line. 
The right panel is coloured according to residue types (negatively 
charged residues, red; positively charged residues, blue). Strongly 
conserved amino acids of Mfd and UvrB are mapped on the surface.  
 
In order to investigate the role of these residues in UvrA binding, UvrA-binding properties 
of Mfd mutants was assayed (table 3.4). 
 
Table 3.4:  Mfd domain 2 mutants used for interaction studies and the 
corresponding residues in Bacillus caldotenax UvrB. Residues marked 
with a star (*) were shown to play a role in UvrA binding in UvrB 
(Truglio et al., 2004). 
Mfd (E.coli) UvrB (B.caldotenax) 
R165A R196* 
R181A R213* 
R181A/D183A R213/E215* 
F185A F217 
E188A E220 
D190A E222 
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3.3.4.3 Interaction of Mfd mutants with UvrA 
In order to analyse the affinities of Mfd mutants to UvrA, wild-type UvrA was 
immobilized on agarose beads. After addition of Mfd mutants, complexes were eluted and 
analyzed by SDS-PAGE. 
The gene encoding wild-type UvrA was cloned into the pET-29 vector (table 2.3), and 
UvrA was expressed with a C-terminal HIS6-tag. An untagged Mfd construct comprising 
the first 586 residues ("Mfd-N5") was used as binding partner. UvrA and Mfd possess a 
similar molecular weight. Therefore, the C-terminally truncated construct of Mfd was used. 
Mfd-N5 consists of the UvrA binding region and the RNA polymerase interacting domain. 
The affinity of this construct to UvrA had been confirmed previously. Mutants were 
generated by PCR-based site-directed mutagenesis from the wild-type gene and cloned into 
the pET-21b vector (table 2.3).  
In a first step, UvrA was bound to Ni2+-NTA resin. After extensive washing, lysates of 
cells expressing Mfd-N5 mutants were added. Lysate from untransformed cells was used 
as negative control. The immobilized proteins were washed carefully with low salt buffer, 
and complexes of UvrA and Mfd-N5 were eluted afterwards. Elution fractions were 
analyzed by SDS-PAGE, and Mfd-N5 containing protein bands were quantified using 
using the Image J software (http://rsb.info.nih.gov/ij/). The levels of UvrA-bound mutants 
were compared to the amount of retained wild-type protein (100 %). 
The experiment was carried out analogously to Truglio et al., 2004, who had analyzed the 
binding properties of UvrB mutants to UvrA. However, a different coupling method had to 
be used. For UvrA-UvrB interaction studies, proteins from Bacillus caldotenax were used. 
B.caldotenax UvrA could be expressed with a C-terminal intein-tag (Chong et al., 1997; 
Chong et al., 1998) and was immobilized on Chitin Beads (NEB, Frankfurt/Main, 
Germany). This system could not be applied for the E.coli protein. The fusion-protein of 
E.coli UvrA and the intein-tag could not be expressed, probably due to its molecular 
weight of ~160 kDa (103.8 kDa for UvrA, 55 kDa for the tag). Interestingly, the 
B.caldotenax protein which is about the same size as E.coli UvrA (105.6 kDa), could be 
produced in E.coli with the large intein-tag. Therefore, E.coli UvrA was immobilized on 
Ni2+-NTA agarose by use of a C-terminal HIS6-tag. Upon addition of Mfd, UvrA “leakage” 
from the resin could be observed (figure 3.22). Therefore, the amount of retained Mfd had 
to be compared to the amount of bound UvrA.  
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Figure 3.22:  UvrA-binding properties of Mfd wild-type protein and domain 2 mutants. 
An exemplary section of an SDS-PAGE analysis is shown. From left to 
right: protein molecular weight marker; negative control (no Mfd); wild-
type Mfd-N5, Mfd mutant R165A. Less UvrA remained bound to the 
Ni2+-NTA resin when wild-type Mfd was added. The mutant R165A 
possessed dramatically decreased affinity to UvrA than wild-type Mfd. 
 
Another problem during evaluation was the strong background level. The interaction 
between UvrA and Mfd (as well as UvrB) is salt-labile (Selby and Sancar, 1993; Hsu et al., 
1995; Truglio et al., 2004). Salt-sensitivity of the complex was tested previously (data not 
shown). Therefore, columns were washed carefully with 100 mM NaCl. Not all impurities 
could be removed (figure 3.22) 
Thus, exact quantification of protein bands was difficult, and values obtained from 
multiple experiments resulted in high standard deviations (see figure 3.23). Nevertheless, 
clear differences between the mutants could be observed. 
While mutants E188A and D190A bound to UvrA at (approximately) wild-type level, the 
mutants R165A, R181A, R181A/D183A and F185 showed a drastically decreased affinity 
to UvrA (figure 3.23 and table 3.5). 
 
Of all mutants analyzed, mutant R165A possesses the lowest affinity to UvrA. Compared 
to wild-type Mfd, only a fifth (18.6%) of protein amount was retained at the UvrA column. 
Residue R165 is absolutely conserved in all known UvrB and Mfd proteins. The 
homologous residue in B.caldotenax UvrB, R196, was also shown to play a role in UvrA 
binding (Truglio et al., 2004). 
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Figure 3.23:  Affinities of different Mfd domain 2 mutants to wild-type UvrA. Shown 
are protein levels of Mfd-N5 which were retained at the UvrA column 
± standard deviation from four independent experiments. 
 
Likewise, residues R181 and D183 seem to be involved in the UvrA-Mfd interaction. Of 
mutant R181A, protein was bound at less than half the amount (42.9%) of wild-type 
protein, the double mutant R181A/D183A was retained at a very low level level of 27.6%. 
R181 (R213 in UvrB) is strictly conserved among UvrB and Mfd. In some Mfd proteins, 
the residue corresponding to D183 (E215) is a glutamate instead of an aspartate, but the 
negatively charged character of this position is maintained in all Mfd and UvrB proteins 
(see figure 3.21). In UvrB, the double mutant R213A/E215A possessed an even lower 
affinity of 12% (table 3.5; Truglio et al., 2004).  
However, affinities of UvrB and Mfd mutants to UvrA were determined by quantification 
of SDS-PAGE bands. Therefore, the exact values obtained should be treated carefully (see 
above). Nevertheless, qualitative results from both experiments were in agreement with 
each other. UvrA-binding seems to require the same residues in Mfd as in UvrB and occurs 
electrostatically in both complexes. 
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Table 3.5:  Protein levels of Mfd mutants bound to UvrA and comparison to the 
corresponding UvrB mutants (Truglio et al., 2004); n.d. = not 
determined 
E.coli Mfd retention B.caldotenax UvrB retention 
R165A 18.6% R194A/R196A 40% 
R181A 42.9% R213A n.d. 
R181A / D183A 27.6% R213A/E215A 12% 
F185A 50.5% F217 n.d. 
∆2 n.d. ∆2 no binding 
 
 
The amino acid F185 is an extremely conserved hydrophobic residue. It is located at the 
"tip" of domain 2 and is unusually solvent-exposed. The F185A mutant showed decreased 
affinity by ca. 50% to UvrA. These findings suggest that F185 might function as an 
"anchor" for the interaction with UvrA. No results are known for the corresponding UvrB 
mutant, but they are expected to be comparable. 
All residues mentioned above are located very close to each other and form a conserved, 
mainly charged "patch" on the surface of Mfd domain 2 (figure 3.21).  
Residues E188 and D190 are located slightly outside this region. Interestingly, the mutants 
E188A and D190A bound to UvrA at wild-type level (96% and 95.6%, respectively). 
Despite the high conservation and the charged character of these solvent exposed residues, 
they do not seem to be of importance for the interaction, probably due to their position. 
An UvrB ∆2 mutant, where the complete domain 2 (residues158-244) was replaced by a 
short linker, does not bind to UvrA at all (Truglio et al., 2004). The same is expected for 
the corresponding Mfd mutant. UvrA-binding properties of an Mfd "∆2" variant will be 
analyzed.  
In order to quantify binding affinities more exactly, a different method should be used. By 
Co-IP, e.g. using anti-HIS-tag antibodies coupled to protein A or protein G beads, UvrA 
"leakage" from the column material could be avoided. In addition, this approach may 
reduce strong background signals. Careful elution would be required to prevent elution of 
the antibody chains (J. Rauch, personal communication).  
Surface plasmon resonance (SPR) is a very powerful method to determine binding 
affinities. SPR is used e.g. in the BIAcore system (BIAcore, Uppsala, Sweden). In order to 
immobilize one binding partner on a chip, chip surfaces with different functional groups 
are available. In this case, covalent coupling of UvrA would be most adequate. Ni2+-coated 
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surface for HIS-tagged proteins would not be recommended as the addition of Mfd lead to 
UvrA leakage (see above).  
 
3.3.5 Functional sites 
3.3.5.1 The Mfd N-terminus does not bind to DNA 
Comparison of the crystal structures of Mfd-N2 and B.caldotenax UvrB revealed a striking 
difference between the two molecules:  
UvrB domain 1B contains a β-hairpin (residues 90-116, magenta in figure 3.16) (Theis et 
al., 1999; Skorvaga et al., 2002; Truglio et al., 2006b). This hairpin is conserved among 
UvrB proteins and is implicated in DNA-binding (Skorvaga et al., 2002). Truglio and 
coworkers could show recently that UvrB binds to DNA by inserting the hairpin between 
the strands of the double helix. This leads to a destabilization of the damaged duplex and 
allows formation of the pre-incision complex. (Truglio et al., 2006b). The β-hairpin is 
essential for discriminating between damaged and non-damaged DNA (Moolenaar et al., 
2001).  
Interestingly, an equivalent to this β-hairpin is missing in Mfd (figure 3.16). At the 
corresponding position, between β2 and αC of domain 1A, only a short, non-functional 
loop (residues 71-84) is present. This loop region is highly conserved among Mfd (see 
3.3.2) and may represent the "base" of a degenerated hairpin.  
 
DNA binding of full-length Mfd as well as of N-terminal constructs was tested by 
electrophoretic mobility shift assay (EMSA). Proteins were incubated with radioactively 
labelled double stranded oligonucleotides. Subsequently, protein-bound DNA was 
separated from free probe by polyacrylamide gel electrophoresis under native conditions. 
DNA-binding by Mfd is dependent on the presence of ATP, whereas ATP-hydrolysis 
disrupts the interaction (Selby and Sancar, 1995a; Selby and Sancar, 1995b). Therefore, the 
experiment was carried out in the presence of ATP-γ-S, a non-hydrolyzable ATP-
analogon.  
 
Full-length Mfd interacts with dsDNA, while the N-terminus of Mfd does not possess any 
DNA binding properties (figure 3.26). 
This is consistent with the findings by Selby and Sancar who showed that ATP-dependent 
interaction between Mfd and double stranded polynucleotides is mediated by the C-
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terminal dsDNA translocase domain of Mfd (see 1.1.2.3). No DNA-binding was reported 
for other regions of Mfd (Selby and Sancar, 1995a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26:  Electrophoretic mobility shift assay (EMSA) of Mfd N-terminal 
constructs and full-length protein. An exemplary PAGE-analysis from 
one out of three independent experiments is shown. The lower band 
corresponds to free DNA probe, the upper band to protein-bound 
oligonucleotides. While full-length Mfd could bind to the probe, the 
constructs showed no affinity to DNA. 
 
In nucleotide excision repair, UvrB uses the β-hairpin to bind to damaged DNA (Skorvaga 
et al., 2002; Truglio et al., 2006b). It is essential for the discrimination between damaged 
and non-damaged DNA (Moolenaar et al., 2001). In Mfd, DNA damage recognition occurs 
by recognition of stalled RNA polymerase (Selby and Sancar, 1993). This is mediated by 
the RNA polymerase interacting domain which is located C-terminal of the UvrA-binding 
region (Selby and Sancar, 1995a). Binding to and translocation along double stranded 
DNA is mediated by the C-terminal translocase module. 
 
3.3.5.2 The Mfd N-terminus contains a degenerated ATPase motif 
The fold of Mfd domain 1A is that of RecA-like domains. However, it lacks the functional 
motifs of active RecA-like ATPases (table 3.6): Walker A motif (identical to helicase 
motif I) residues are involved in nucleotide binding and positioning of the γ-phosphate. 
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Residues of the Walker B motif (DExx, helicase motif II) coordinate the magnesium ion 
and polarize the water molecule for nucleophilic attack (Walker et al., 1982). 
In UvrB domain 1A, the functional ATPase motifs are present. UvrB is an ATP-dependent 
helicase. By itself, it only possesses cryptic ATPase activity which is activated in the 
presence of UvrA and damaged DNA. Full-length UvrB possesses a C-terminal regulatory 
domain 4 which inhibits DNA binding and ATPase activity in the absence of UvrA (Caron 
and Grossman, 1988; Wang et al., 2006). C-terminally truncated UvrB lacking this 
autoinhibitory domain shows increased binding to DNA and enhanced ATPase activity 
(Wang et al., 2006). 
 
Table 3.6:  Alignment of Walker A and Walker B motifs from UvrB proteins and the 
corresponding regions in Mfd. "o" stands for hydrophobic residues, 
residues coloured in green are in accordance with the canonical 
sequences. 
Walker A  Walker B  
consensus       G  G GK(S/T) consensus  oooDESH 
EcoUvrB QTLLGVTGSGKT EcoUvrB LLVVDESHV 
BsuUvrB QTLLGATGTGKT BsuUvrB MIVVDESHV 
HinUvrB QTLLGVTGSGKT HinUvrB ILIIDESHV 
MtuUvrB VVLLGATGTGKS MtuUvrB LLVIDESHV 
BcaUvrB QTLLGATGTGKT BcaUvrB LIIVDESHV 
EcoMfd RLLGELTGAACA EcoMfd LLVNTG-DL 
BsuMfd QLLAGLSGSARS BsuMfd LLILDEVSR 
HinMfd KILGNVLPGADA HinMfd LFVDME--N 
MtuMfd DELTLIAPASAR MtuMfd PVLVCDPEK 
 
 
In B.caldotenax UvrB, residues Thr41, Gly42, Thr43 and Lys45 of helicase motif I are 
involved in phosphate binding (Theis et al., 1999). In Mfd-N2, the corresponding region 
was not ordered in the crystal structure. Sequence alignment (table 3.6) indicates that the 
canonical Walker A residues are not present in Mfd.  
 
Side chains of the conserved amino acids Glu338 and Asp339 of helicase motif II point 
toward the Mg2+-ion in UvrB (Theis et al., 1999). The corresponding region in Mfd lacks 
these acidic residues (figure 3.24). In addition, the typical three-dimensional conformation 
of active ATPases cannot be found in Mfd. 
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Figure 3.24:  Detailed view of the Walker B (DESH) motif of ATP-bound UvrB (PDB-
ID 1D9Z; Theis et al., 1999) and the corresponding region of Mfd 
(domain 1A, orange; domain 1B, blue; non-carbon atoms are coloured 
according to the atom type: magnesium, grey; nitrogen, green; oxygen, 
red; phosphorus, magenta). 
 
Interestingly, the "Walker A" and "Walker B" motifs of Bacillus subtilis Mfd show higher 
similarity to the canonical sequences (table 3.6). Therefore the B.subtilis Mfd N-terminus 
might be able to bind and/or hydrolyze ATP. 
 
ATPase activity of different N-terminal constructs was tested by thin layer 
chromatography. As controls, Mfd-FL (see 3.1) and UvrB-N were used.  
UvrB-N comprises the first 583 residues of E.coli UvrB. It lacks the regulatory C-terminal 
domain 4. The gene encoding UvrB residues 1-583 was amplified by PCR from genomic 
E.coli XL1 Blue DNA and cloned into the pET-21b vector (table 2.3). UvrB-N was 
expressed with a C-terminal hexahistidine-tag and purified analogously to Mfd-N2.  
ATPase activity was determined in the absence (light blue) and in the presence (violet) of 
dsDNA (figure 3.25). 
UvrB      Mfd 
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Figure 3.25:  ATPase activity assay of Mfd-N2 (1-333), Mfd-N4 (1-433), Mfd-N6 
(1-586), Mfd-FL and UvrB-N (1-583) without (light blue) and with 
(violet) dsDNA. Shown are mean values and standard deviation of three 
independent experiments.  
 
It could be shown that the Mfd N–terminus does not possess ATPase activity. Full-length 
Mfd is able to hydrolyze ATP by use of its C-terminal dsDNA translocase domain (Selby 
and Sancar, 1995b) (see 1.1.2.3). Constructs Mfd-N2, Mfd-N4 and Mfd-N6 lacking the C-
terminus are not able to hydrolyze ATP. UvrB-N contains functional Walker A and Walker 
B motifs and possesses DNA-stimulated ATPase activity (Caron and Grossman, 1988; 
Theis et al., 1999).  
 
ATP binding and hydrolysis by UvrB are required in two steps of nucleotide excision 
repair: UvrA-mediated loading of UvrB onto damaged DNA does not only require ATP 
hydrolysis by UvrA but also by UvrB (Van Houten et al., 1988; Moolenaar et al., 2000). 
UvrB probably destabilizes the DNA duplex in an energy-consuming reaction in order to 
insert the β-hairpin between the strands (Goosen and Moolenaar, 2001; Truglio et al., 
2006b). UvrC-mediated incision into the damaged DNA requires binding of a new ATP 
molecule by UvrB (Orren and Sancar, 1990; Moolenaar et al., 2000; Truglio et al., 2005). 
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This induces a conformational change in the DNA, resulting in higher sensitivity to 
nucleases (Moolenaar et al., 2000).  
In contrast, Mfd acts on sites of transcription. Here, the DNA double helix has already 
been opened (Selby and Sancar, 1994). In the incision reactions, Mfd is not involved. 
Therefore, functional ATPase motifs are not essential in this region of Mfd. 
Full-length Mfd does possess ATPase activity. Mfd translocates along double stranded 
DNA in an ATP-dependent manner. ATPase activity is also used for the dissociation of 
stalled RNA polymerase. ATP hydrolysis is carried out by the C-terminal translocase 
domain (Selby and Sancar, 1995a; Selby and Sancar, 1995b).  
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4 Discussion 
 
Cells frequently encounter DNA damage caused by variable exo- or endogeneous sources. 
DNA lesions are a severe threat to genomic integrity and can lead to mutations, cancer, or 
cell death. Therefore, different DNA repair mechanisms exist in order to deal with all 
different types of lesions (reviewed in Lindahl and Wood, 1999; Lodish et al., 2000; 
Hoeijmakers, 2001; Friedberg et al., 2006) 
Bulky DNA lesions that affect structure of the DNA double helix are repaired by a 
mechanism called nucleotide excision repair (NER). NER can be found in all kingdoms of 
life and is functionally conserved throughout evolution (Sancar, 1996; Ogrunc et al., 1998; 
Batty and Wood, 2000). In baceria, nucleotide excision repair is performed by the UvrABC 
system (Van Houten et al., 2005; Truglio et al., 2006a). 
DNA damage in active genes is repaired by a special mode of NER, called transcription-
coupled repair (TCR). Non-coding lesions in the transcribed strand cause transcription 
elongation complexes to arrest. A "transcription-repair coupling factor" functions in the 
release of arrested RNA polymerase and delivers the NER machinery to the lesion-site. 
 
Aim of this work was to gain structural insights into the mechanism of bacterial 
transcription-coupled repair. During this PhD thesis, the crystal structure of the N-terminal 
333 residues of the Escherichia coli transcription-repair coupling factor, the Mfd protein, 
was solved. The Mfd N-terminus binds to the nucleotide excision repair protein UvrA and 
is involved in the recruitment of the UvrABC repair system to DNA lesions at stalled 
transcription sites. The interaction between Mfd and UvrA was further analyzed 
biochemically in order to reveal mechanistic details of this process.  
 
4.1 The Mfd N-terminus resembles UvrB 
The Mfd N-terminus has a triangular structure consisting of three domains (domains 1A, 
1B and 2). The structure of the Mfd N-terminus very much resembles the architecture of 
the three N-terminal domains of UvrB (also denoted domain 1A, 1B and 2, respectively). 
However, it lacks functional elements that are implicated in ATP-driven damage 
recognition of UvrB (Theis et al., 1999; Moolenaar et al., 2000; Truglio et al., 2006b).  
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Both in Mfd and UvrB, the N-terminus is implicated in UvrA-binding. In Mfd, this is the 
only function associated with this region (Hsu et al., 1995; Selby and Sancar, 1995a; Selby 
and Sancar, 1995b). Both in Mfd and in UvrB, the interaction to UvrA is mediated by 
domain 2 (Hsu et al., 1995; Truglio et al., 2004, and this work). Domain 2 of Mfd 
possesses high sequence homology to UvrB as well as close structural similarity (Selby 
and Sancar, 1993; Truglio et al., 2004, and this work). In both proteins, strongly conserved 
residues are located at the surface of domain 2. Several of these residues could be shown to 
be essential for UvrA-binding both in UvrB and in Mfd (Truglio et al., 2004, and this 
work). Therefore, binding to UvrA seems not only to be a conserved function between 
UvrB and Mfd. In addition, both proteins seem to use a similar mechanism. 
 
In UvrB, two additional activities reside within the N-terminus. The UvrB protein is a 
weak helicase and possesses cryptic ATPase activity. Functional ATPase motifs are 
located in domain 1A (Caron and Grossman, 1988; Hsu et al., 1995; Theis et al., 1999). In 
contrast, the corresponding region of Mfd does not adopt the conformation of active 
ATPases. Only a degenerated ATPase motif can be found in domain 1A. We could confirm 
that the Mfd N-terminus is not able to hydrolyze ATP (Selby and Sancar, 1995a; Selby and 
Sancar, 1995b).  
Domain 1B of UvrB contains a conserved β-hairpin motif which functions in DNA binding 
(Theis et al., 1999; Skorvaga et al., 2002; Truglio et al., 2006b). In Mfd, the corresponding 
region is more compact and lacks the DNA-binding motif. Instead, a short, non-functional 
loop can be found which may correspond to a degenerated hairpin. No DNA binding can 
be found for this part of Mfd.  
 
However, the fold and overall arrangement of domains 1A and 1B is conserved in Mfd. In 
UvrB as well as in Mfd, the three N-terminal domains form a compact module with a 
central domain 1A. Domains 1B and 2 are inserted into the primary sequence of domain 
1A (Theis et al., 1999; Truglio et al., 2006b, and this work). Hence, domains 1A and 1B 
may play an important role in forming the architecture of the N-terminal module.  
 
UvrB possesses a second RecA-like domain, domain 3, which is located beside the 
compact module of domains 1A, 1B and 2 (Theis et al., 1999). Domain 3, together with 
domain 1A, forms the "helicase" motor of UvrB (Hsu et al., 1995). Domain 3 as well as a 
regulatory domain 4 (Sohi et al., 2000; Wang et al., 2006) are not present in Mfd 
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(Deaconescu et al., 2006). These domains do not contribute to the compact structure of 
domains 1A, 1B and 2. In addition, their primary sequence is found C-terminal of domains 
1A/1B/2.  
 
Taken together, these findings suggest that the N-terminal part of Mfd might have evolved 
from an UvrB molecule or from a common precursor: Mfd and UvrB have a common 
function by binding to UvrA. In both proteins, this function is mediated by the highly 
conserved domain 2. No biochemical function is associated with domains 1A and 1B in 
Mfd. They seem to be involved in maintaining the architecture of the compact module. In 
UvrB, additional functional motifs are present. Nucleic acid binding and ATP hydrolysis 
are mediated by the N-terminal region. There is evidence that these activities might have 
been present in an Mfd precursor, but – as they are not required for the function of Mfd – 
have been degenerated. 
 
For most other functional domains of Mfd, "counterparts" can be found as well: 
The RNA polymerase interacting domain resembles the KOW domain of the bacterial 
transcripton factor NusG wich is believed to function in RNA polymerase binding as well 
(Li et al., 1992; Steiner et al., 2002; Deaconescu et al., 2006). 
The RecG homology module located in the C-terminal half of Mfd, possesses motifs 
related to superfamily II helicases (Selby and Sancar, 1993; Selby and Sancar, 1995b). It 
possesses high sequence homology to RecG (Chambers et al., 2003; Mahdi et al., 2003), 
and both proteins share structural similarity (Singleton et al., 2001; Deaconescu et al., 
2006). In both proteins, this region was found to function as dsDNA translocase (Singleton 
et al., 2001; Park et al., 2002).  
Swi2/Snf2 ATPases translocate on double stranded DNA by travelling along both minor 
groove backbone strands (Durr et al., 2005). Structural resemblance of the Mfd translocase 
domain to the Sulfolobus solfataricus Swi2/Snf2 ATPase suggests a similar translocation 
mechanism for Mfd (Deaconescu et al., 2006).  
The domain which is unique to the Mfd protein is the very C-terminal TRCF domain 
which protects the UvrA-binding surface. This domain revealed a novel protein fold with 
only very weak similarity to the Rpb1 subunit of eukaryotic RNA polymerase II (Selby and 
Sancar, 1993; Cramer et al., 2001; Deaconescu et al., 2006). 
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The crystal structure of the Mfd N-terminus provides a first structural insight into bacterial 
TCR. The remarkable similarity between Mfd and UvrB indicates an evolutionary 
connection between global genome and transcription-coupled nucleotide excision repair. In 
addition, it suggests a mechanism by which Mfd might form an UvrA recruitment factor at 
stalled transcription complexes. 
 
4.2 The role of Mfd in recruitment of the UvrA-UvrB complex 
In bacterial nucleotide excision repair, DNA damage recognition is performed by the 
UvrA2-UvrB1/2 complex (Orren and Sancar, 1989; Mazur and Grossman, 1991). Upon 
damage verification, the UvrB-DNA pre-incision complex (PIC) is formed by the action of 
UvrA: UvrA loads UvrB onto the damaged DNA in an energy-consuming reaction. This 
step is the rate-limiting reaction in the nucleotide excision repair process (figure 4.1, left 
panel) (Van Houten et al., 1988; Orren and Sancar, 1990; Myles et al., 1991). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1:  Recruitment of the UvrAB complex and formation of the pre-incision 
complex (PIC) in global genome (left panel) and in transcription-
coupled nucleotide excision repair (right panel) (DNA lesion, red star; 
Mfd, yellow; UvrA, orange; UvrB, green). 
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In transcription-coupled repair, DNA damage is recognized by elongating RNA 
polymerase. As consequence, RNA polymerase becomes arrested (Tornaletti and 
Hanawalt, 1999). Arrested RNA polymerase is recognized and subsequently released by 
the transcription-repair coupling factor, Mfd (Selby and Sancar, 1995b; Park et al., 2002). 
Mfd itself remains bound at the lesion site and recruits the nucleotide excision repair 
system to the lesion site (Selby et al., 1991; Selby and Sancar, 1993; Roberts and Park, 
2004). However, the mechanistic details of UvrAB recruitment and the subsequent 
formation of the UvrB-DNA pre-incision complex at stalled transcription sites are not fully 
understood (figure 4.1, right panel).  
 
So, what could be the function of Mfd in these steps? 
The role of Mfd seems to involve binding to UvrA. Mfd can interact directly with UvrA 
(Selby and Sancar, 1995a). There is high evidence that Mfd and UvrB use a similar mode 
of binding to UvrA: High structural similarity of domain 2 can be found, and in both 
proteins, highly conserved residues are essential for UvrA binding (Truglio et al., 2004, 
and this work). In addition, UvrB can be displaced from UvrA by Mfd in vitro (Selby and 
Sancar, 1993). These findings suggest that Mfd and UvrB compete for binding to UvrA. 
 
In vitro, Mfd can bind directly to the UvrA dimer (Mazur and Grossman, 1991). However, 
the existence of a free UvrA2-Mfd complex in vivo is rather unlikely. In full-length Mfd, 
the UvrA binding region is buried in the interface between domain 2 and the TCRF domain 
(denoted domain 7), and therefore seems to be protected (Deaconescu et al., 2006). A 
C-terminally truncated version of Mfd lacking domain 7 causes defects not only in 
transcription-coupled repair but also in global nucleotide excision repair by interacting 
with UvrA in an unproductive manner (Selby and Sancar, 1995a). Hence, UvrA and Mfd 
are not likely to interact independently of transcriptional arrest. Deaconescu and colleagues 
suggest that, upon binding to RNA polymerase, Mfd undergoes conformational changes by 
which the UvrA binding domain becomes surface-exposed and thus accessible 
(Deaconescu et al., 2006). Therefore, in contrast to UvrB, Mfd seems to interact with 
UvrA only at sites of arrested transcription.  
 
After binding to RNA polymerase and its dissociation, Mfd remains bound at the DNA in 
close proximity to the damage site (Selby et al., 1991; Selby and Sancar, 1993; Roberts 
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and Park, 2004). Thus, the exposed UvrA-binding region of Mfd may act as recruitment 
signal for UvrA and attract the UvrA-UvrB complex.  
The subsequent formation of the UvrB-DNA pre-incision complex probably involves Mfd 
as well (see below).  
 
On the other hand, it is also possible that Mfd only attracts the UvrAB complex to the 
lesion site and does not take part in the subsequent reaction ("attraction model", figure 4.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2:  Attraction model: Mfd attracts the UvrAB complex close to the damage 
site. The formation of the pre-incision complex occurs independently of 
Mfd (colour code as in figure 4.1).  
 
Damage repair in active genes occurs at a much higher rate than in the overall genome 
(Mellon et al., 1986; Mellon et al., 1987; Mellon and Hanawalt, 1989). The rate limiting 
step in global nucleotide excision repair is the UvrA-dependent loading of UvrB onto the 
damaged DNA (Orren and Sancar, 1990). Therefore, this step is probably facilitated in 
transcription-coupled repair (Selby and Sancar, 1995b).  
One difference between global and transcription-coupled nucleotide excision repair 
concerning this reaction is quite evident: During formation of the pre-incision complex, 
UvrB inserts a β-hairpin motif between the two strands of the DNA double helix (Truglio 
et al., 2006b). In global NER, the UvrAB complex acts on double stranded DNA, and the 
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DNA duplex has to be destabilized beforehand. This requires ATP-hydrolysis by UvrB. 
Before UvrC can incise the damaged DNA, a new ATP molecule has to be bound by UvrB 
resulting in conformational changes in the DNA molecule (Moolenaar et al., 2000; Goosen 
and Moolenaar, 2001). In contrast, TCR takes place at transcription bubbles where the 
DNA double helix has already been opened (Selby and Sancar, 1994). UvrB can insert the 
hairpin without hydrolysis and rebinding of ATP. Mfd possesses affinity to transcription-
bubble like DNA structures in vitro (Selby and Sancar, 1995a). It therefore is imaginable 
that Mfd forms a "placeholder", until the UvrA-UvrB complex approaches the damage site. 
This feature probably has an effect on the repair rate. However, by itself, it is presumably 
insufficient to explain the dramatical discrepancies in the repair rates between global and 
transcription-coupled repair. 
 
Mfd might therefore also be actively involved in the formation of the UvrB-DNA complex. 
Mfd is able to displace UvrB from UvrA in vitro (Selby and Sancar, 1993). Hence, Mfd 
could also help to release UvrA from UvrB in vivo. 
Recognition of lesion-bound Mfd may promote the dissociation of the UvrAB complex 
and, in consequence, enhances formation of the UvrB-DNA pre-incision complex. UvrB-
loading is an energy-consuming reaction (Myles et al., 1991). Thus, it would be interesting 
to investigate, if ATPase-activity of UvrA can be stimulated by the presence of Mfd.  
 
In this scenario, Mfd directly interacts with UvrA which is still involved in the UvrA2-
UvrB complex. As mentioned above, Mfd and UvrB seem to interact with UvrA in a 
highly similar way (see above). It is therefore quite likely that Mfd and UvrB compete for 
the same binding site on UvrA ("competitive model"). On the other hand, it is also 
imaginable that Mfd induces conformational changes in UvrA leading to UvrB-release. 
This would require a second, allosteric binding site on UvrA. 
 
Although much is known about the UvrA-binding domains of UvrB and Mfd, the 
UvrB-/Mfd-interacting region of UvrA is only poorly understood. The UvrB-binding site 
of UvrA could be narrowed down to the first 230 amino acids (Claassen and Grossman, 
1991). For binding of UvrB or Mfd, dimerization of UvrA is essential (Claassen and 
Grossman, 1991; Myles et al., 1991). This is achieved at high concentrations of UvrA or in 
the presence of ATP (Myles et al., 1991). At physiological concentrations, most UvrA is 
present as a dimer in the UvrA2-UvrB1/2 complex (Orren and Sancar, 1989).  
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UvrA contains two ABC ATPase domains (Doolittle et al., 1986). The N-terminal ATPase 
motifs are involved in dimer formation. They are located within the UvrB-binding region 
(Myles et al., 1991). It is therefore imaginable that two equivalent binding sites for 
UvrB/Mfd are present in one UvrA dimer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Allosteric model:According to this model, Mfd directly takes part in the 
release of UvrB from UvrA and in the formation of the PIC. This 
reaction may involve a transient quaternary complex.  
 
Properties of the UvrA-UvrB complex have been intensively studied. There is no evidence 
that two UvrB molecules can bind to different sites on UvrA simultaneously. Due to 
intrinsic asymmetry, only one binding site may therefore be occupied at one time. In this 
case, binding at one site by Mfd may induce conformational changes in UvrA leading to 
the release of UvrB at the other binding site. This displacement-mechanism certainly 
would accelerate the process of pre-incision complex formation. It would require the 
presence of a short-living quarterny complex containing both UvrB and Mfd ("allosteric 
model", figure 4.3). In order to confirm the existence of such a complex, fluorescence 
methods, like fluorescence correlation spectroscopy (FCS), could be applied.  
 
According to the latter models, Mfd is directly involved in the dissociation of the UvrA-
UvrB complex and hence in the formation of the UvrB-DNA pre-incision complex.  
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5 Summary 
 
The Mfd (mutation frequency decline) protein is responsible for connecting the cellular 
processes of transcription and DNA repair in bacteria. Mfd, also termed transcription-
repair coupling factor (TRCF), recognizes arrested transcription elongation complexes and 
catalyzes their dissociation from damaged template DNA in an ATP-dependent manner. 
Subsequently, Mfd recruits the UvrABC nucleotide excision repair machinery to the 
damage site. The mechanistic details of this process are not fully understood.  
X-ray crystallography was used in order to give structural insights into the mechanism of 
bacterial transcription-coupled repair. During this PhD thesis, the crystal structure of the 
N-terminus (residues 1-333) of Escherichia coli Mfd ("Mfd-N2") was solved. The Mfd 
N-terminus is implicated to function in UvrA-binding. It bears a region with high 
homology to the nucleotide excision repair protein UvrB. 
Mfd-N2 is a triangularly shaped molecule of approximately 60×60×30 Å dimensions 
which contains three structural domains (domains 1A, 1B and 2). Interestingly, the 
structure of Mfd-N2 very much resembles that of the three N-terminal domains of UvrB. 
Mfd domain 1A adopts a typical RecA fold. However, it lacks the functional motifs of 
active ATPases, and we could confirm that the Mfd N-terminus does not possess any 
ATPase activity. Domain 1B matches the damage-binding domain of the UvrB. 
Interestingly, Mfd is bereft of the damage-binding motif of UvrB domain 1B, and no DNA 
binding is associated with this part of Mfd. Domain 2, which possesses the highest 
sequence homology to UvrB, closely matches the three-dimensional structure of the 
implicated UvrA-binding domain of UvrB.  
Highly conserved amino acids between Mfd and UvrB can be found on the surface of 
domain 2. Using site-directed mutagenesis, several of these residues could be shown to 
function in the UvrA-Mfd interaction. Remarkably, the corresponding residues in UvrB are 
required for productive interaction between UvrA and UvrB as well. 
Taken together, these results suggest that Mfd and UvrB interact with UvrA in a similar 
manner. Mfd may form an UvrA-recruitment factor at stalled transcription complexes that 
resembles UvrB architecturally but not catalytically. The molecular similarity between 
Mfd and UvrB indicates an evolutionary connection between global genome and 
transcription-coupled nucleotide excision repair in bacteria. 
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7.1 Stable fragments of Mfd 
Band 0: Mfd-FL (control) 
MASMPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDE 
ISQFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCP 
HSFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY 
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRDP 
EHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTLAR 
FENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPDLAV 
QAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASDRGRY 
LMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIGQPVVH 
LEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENAPLHKLG 
GDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFETTPDQAQ 
AINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTLLAQQHYDN 
FRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKFKDLGLLIVD 
EEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPPARRLAVKTFV 
REYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAIGHGQMRERELE 
RVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLRGRVGRSHHQAYA 
WLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLGEEQSGSMETIGFS 
LYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDVNTRLSFYKRIASAK 
TENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEGNEKGGVIEFAEKNHV 
NPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMRELEENAIAAAALEHHH 
HHH& 
 
Band 1 (approximately 35 kDa) 
MASMPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDE 
ISQFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCP 
HSFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY 
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRDP 
EHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTLAR 
FENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPDLAV 
QAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASDRGRY 
LMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIGQPVVH 
LEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENAPLHKLG 
GDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFETTPDQAQ 
AINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTLLAQQHYDN 
FRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKFKDLGLLIVD 
EEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPPARRLAVKTFV 
REYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAIGHGQMRERELE 
RVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLRGRVGRSHHQAYA 
WLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLGEEQSGSMETIGFS 
LYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDVNTRLSFYKRIASAK 
TENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEGNEKGGVIEFAEKNHV 
NPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMRELEENAIAAAALEHHH 
HHH& 
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Band 2 (approximately 50 kDa) 
MASMPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDE
ISQFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCP
HSFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRDP
EHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTLAR
FENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPDLAV
QAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASDRGRY
LMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIGQPVVH
LEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENAPLHKLG
GDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFETTPDQAQ
AINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTLLAQQHYDN
FRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKFKDLGLLIVD
EEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPPARRLAVKTFV
REYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAIGHGQMRERELE
RVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLRGRVGRSHHQAYA
WLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLGEEQSGSMETIGFS
LYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDVNTRLSFYKRIASAK
TENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEGNEKGGVIEFAEKNHV
NPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMRELEENAIAAAALEHHH
HHH& 
 
Band 3 (approximately 60 kDa) 
MASMPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDE
ISQFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCP
HSFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRDP
EHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTLAR
FENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPDLAV
QAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASDRGRY
LMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIGQPVVH
LEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENAPLHKLG
GDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFETTPDQAQ
AINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTLLAQQHYDN
FRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKFKDLGLLIVD
EEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPPARRLAVKTFV
REYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAIGHGQMRERELE
RVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLRGRVGRSHHQAYA
WLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLGEEQSGSMETIGFS
LYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDVNTRLSFYKRIASAK
TENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEGNEKGGVIEFAEKNHV
NPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMRELEENAIAAAALEHHH
HHH& 
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Band 4 (approximately 50 kDa) 
MASMPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDE
ISQFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCP
HSFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRDP
EHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTLAR
FENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPDLAV
QAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASDRGRY
LMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIGQPVVH
LEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENAPLHKLG
GDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFETTPDQAQ
AINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTLLAQQHYDN
FRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKFKDLGLLIVD
EEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPPARRLAVKTFV
REYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAIGHGQMRERELE
RVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLRGRVGRSHHQAYA
WLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLGEEQSGSMETIGFS
LYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDVNTRLSFYKRIASAK
TENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEGNEKGGVIEFAEKNHV
NPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMRELEENAIAAAALEHHH
HHH& 
 
Band 5 (approximately 18 kDa) 
MASMPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDE
ISQFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCP
HSFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRDP
EHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTLAR
FENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPDLAV
QAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASDRGRY
LMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIGQPVVH
LEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENAPLHKLG
GDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFETTPDQAQ
AINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTLLAQQHYDN
FRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKFKDLGLLIVD
EEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPPARRLAVKTFV
REYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAIGHGQMRERELE
RVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLRGRVGRSHHQAYA
WLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLGEEQSGSMETIGFS
LYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDVNTRLSFYKRIASAK
TENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEGNEKGGVIEFAEKNHV
NPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMRELEENAIAAAALEHHH
HHH& 
 
Peptides found by mass spectrometry are shaded in light grey. The dotted line corresponds 
to the next peptide found in the full-length protein and/or in larger fragments. Residues 
which were identified by EDMAN-sequencing are underscored in bold. 
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7.2 Abbrevations 
Å   ångström (=10-10 m) 
AA   amino acid or residue 
ACN   acetonitrile 
ATP   adenosine triphosphate 
ATP-γ-S  adenosine 5'-O-(thio-triphosphate) 
Bca   Bacillus caldotenax 
BER   base excision repair 
bp    base pair(s) 
BSA   bovine serum albumin 
Bca   Bacillus caldotenax 
Bsu   Bacillus subtilis 
ca.  circa 
CHCA  α-cyano-4-hydroxy-cinnamic acid 
CS  Cockayne's syndrome 
Dali  distance matrix alignment 
DNA   deoxyribonucleic acid 
dsDNA  double stranded DNA 
DSB   double strand break 
Eco / E.coli  Escherichia coli 
e.g.  exempli gratia (for example) 
EMSA  electrophoretic mobility shift assay 
GGR   global genome repair 
Hin    Haemophilus influenza 
HPLC   high performance liquid chromatography 
HR  homologous recombination 
IEX   ion exchange chromatography 
kb   kilobase pair(s); 
LB   Luria-Bertani 
M   molar 
MAD  multiple-wavelength anomalous dispersion 
MALDI  matrix-assisted laser desorption ionisation 
Mfd   mutation frequency decline 
MMR   mismatch repair 
MR   molecular replacement 
MS   mass spectrometry 
Mtu    Mycobacterium tubercolosis 
mut   mutator 
NCBI   National Center for Biotechnology Information 
n.d.   not determined 
NER   nucleotide excision repair 
NHEJ   non-homologous end-joining 
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NMR  nuclear magnetic resonance spectroscopy 
o/n   over night 
PAGE   polyacrylamide gel electrophoresis 
PCR   polymerase chain reaction 
PDB   Protein Data Bank 
PEG   polyethylene glycol 
PEI   polyethyleneimine 
pI   isoelectric point 
PIC   pre-incision complex 
PEG   polyethylene glycol 
PMSF  phenyl methyl sulfonyl fluorid 
PNK   polynucleotide kinase 
PVDF   polyvinyliden fluorid 
RID  RNA polymerase interacting domain 
RMSD   root mean square deviation 
RNA   ribonucleic acid 
RNAP   RNA polymerase 
RNAPII  eukaryotic RNA polymerase II 
RPA   replication protein A 
RP-HPLC  reversed phase HPLC 
SAD  single-wavelength anomalous diffraction 
SDS   sodium dodecyl sulfate 
SPR   surface plasmon resonance 
ssDNA  single stranded DNA 
TB   tris-borate 
TCR   transcription-coupled repair 
TEC  transcription elongation complex 
TF   transcription factor 
TFA   trifluoroacetic acid 
TLC   thin layer chromatography 
TLS   translesion synthesis 
ToF   Time-of-Flight 
TRCF  transcription-repair coupling factor 
TRG   translocation in RecG 
v   volume 
w   weight 
w/o   without 
wt   wild-type 
XP   xeroderma pigmentosum 
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7.3 Aminoacids and nucleotides 
One letter code Three letter code Amino acid 
A Ala alanine 
B Asx asparagine or aspartic acid 
C Cys cystein 
D Asp aspartic acid 
E Glu glutamic acid 
F Phe Phenylalanine 
G Gly glycine 
H His histidine 
I Ile isoleucine 
L Leu leucine 
K Lys lysine 
M Met methionine 
N Asn asparagine 
P Pro proline 
Q Gln glutamine 
R Arg arginine 
S Ser serine 
T Thr threonine 
V Val valine 
W Trp tryptophan 
X Xaa unknown or other 
Y Tyr tyrosine 
Z Glx glutamine or glutamic acid 
 
 
One-letter code Nucleobase 
A adenine 
C cytosine 
G guanine 
T thymine 
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